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Enhanced Recovery After Surgery
After studying several aspects of postoperative recovery in the mid-eighties and 
nineties, Hendrik Kehlet proposed a multimodal approach to improve postoperative
recovery in 1997, nowadays known as Enhanced Recovery After Surgery (ERAS).(1)
The program aims to reduce the surgical stress response with subsequent increased 
demands on organ function.       
All elements in the program have shown to improve patient outcome separately. 
Preoperative information about postoperative care reduces anxiety and improves 
patient participation. Preoperative carbohydrate loading diminishes insulin resistance 
and results in a better gastrointestinal function.(2,3) Avoidance of bowel preparation 
results in less discomfort and electrolyte disturbance.(4-8) Epidural anaesthesia 
provides adequate reduction of postoperative pain, without the need of systemic 
opioids that hamper the central nervous system, respiratory and gastrointestinal 
function. (9-11) Restricted intraoperative fluid therapy reduces morbidity, the  
time to recovery of gastrointestinal function and hospital stay.(12,13)  
Early start of enteral feeding diminishes mortality, morbidity and hospital 
stay, (14) whereas early mobilization prevents pulmonary complications.(10) 
All elements are implemented in a multimodal strategy aiming at enhancing  
recovery and reducing the stress response after surgery. 
In 2006, the enhanced recovery program was introduced in the Department 
of Surgery of the Radboud University Nijmegen Medical Centre, Nijmegen, 
the Netherlands. The effects of this program are evaluated in this thesis.
In order to assess the influence of an enhanced recovery program and to 
compare the results with conventional treatment regimens, it is of utmost 
importance to adequately define patient groups. Before starting the evaluation of 
the ERAS program a study was done to evaluate different scoring systems to assess 
patient’s risk of complications or death. The Physiological and Operative 
Severity Score for the eNumeration of Mortality and morbidity (POSSUM) scoring 
systems was developed in 1991.(15) In 1998 the Portsmouth POSSUM was found 
to have a higher predictive value than the initial model. In 2003, the Association 
of Coloproctology of Great Britain and Ireland (ACPGBI) developed its own 
scoring system for surgical patients with colorectal cancer. The inaccuracies 
of the previous POSSUM scores led to the introduction of the specialty-specific 
ColoRectal POSSUM score in 2004.(16) In Chapter 2, the value of POSSUM and 
ACPGBI risk prediction in surgery is assessed in a retrospective case-control 
study including patients with colorectal cancer and benign colorectal diseases.
Enhanced recovery after surgery protocols aim at reducing the surgical stress 
response and optimizing recovery, thus reducing the length of hospital stay. 
However, there have been concerns regarding protocol compliance, high  
readmission rates and the true impact on morbidity.   
In Chapter 3,the mortality, morbidity and in-hospital stay after colorectal surgery
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of patients treated following the ERAS protocol is compared with a cohort of carefully 
matched patients who received conventional postoperative care.  
Rectal surgery differs from colonic surgery and is associated with higher complication 
rates and a longer hospital stay.(17) In Chapter 4 the impact of Enhanced   
Recovery after Surgery on postoperative recovery in rectal surgery is described in a 
case-matched cohort study.         
Although the separate elements of Enhanced Recovery After Surgery have proven 
to be helpful in the recovery of patients and the evidence on the beneficial effects 
of the ERAS package is accumulating, it is not clear which elements have most 
impact on early recovery. (18-23) The clinical impact of individual elements of the 
fast track program is evaluated in Chapter 5. Especially the role of early feeding, 
mobilization, epidural anaesthesia and restricted fluid therapy is elaborated. As a 
consequence of our findings, a systemic review and meta-analysis was performed to 
determine if intraoperative fluid management by the use of oesophageal Doppler 
could improve the outcome of patients undergoing colorectal surgery (Chapter 6).
One of the consequences of the implementation of an enhanced recovery program  
is a shorter hospital stay. Anastomotic leakage is one of the most serious adverse 
events after colorectal surgery. Its reported incidence varies from 1-25%.(24) 
Diagnosing leaks relies on the clinical and radiographic findings. Early diagnosis 
and prompt treatment are essential since delay is associated with increased 
mortality and morbidity.(25,26) Radiological diagnosis by means of e.g. contrast 
radiography or computer tomography are often advised when anastomotic 
dehiscence is suspected. However, sensitivity of both contrast radiography and 
computer tomography for diagnosing anastomotic dehiscence are rather low, being 
65% and 54% respectively. Interobserver variability may be as high as 10 %.(27,28) 
Since leakage of bowel contents elicits at least a local inflammatory response, 
F-18-fluorodeoxyglucose positron emission tomography (FDG-PET) may be a 
promising imaging technique to improve the detection of anastomotic bowel 
leak, at an early stage when granulocytes and macrophages migrate to the 
inflammatory process.(29-31) A first condition for such an application would be 
that the signal remains low during undisturbed healing. Chapter 7 describes 
postoperative FDG uptake in colonic and colorectal anastomosis in patients 
without evidence of active infection or anastomotic leakage. 
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Abstract
Background
Preoperative risk prediction to assess mortality and morbidity may be helpful 
to surgical decision-making. The aim of this study was to compare mortality 
and morbidity of colorectal resections performed in a tertiary referral center 
with mortality and morbidity as predicted with Physiological and Operative 
Score for enUmeration of Mortality and morbidity (POSSUM), Portsmouth-
POSSUM and Colorectal-POSSUM. The second aim of this study was to analyze 
the accuracy of different POSSUM-scores in surgery performed for malignancy, 
inflammatory bowel diseases and diverticulitis. POSSUM scoring was also 
evaluated in colorectal resection in acute versus elective setting. In procedures 
performed for malignancy, the Association of Coloproctology of Great Britain 
and Ireland (ACPGBI) score was assessed in the same way for comparison.
Methods
POSSUM, P-POSSUM and CR-POSSUM predictor equations for mortality 
were applied in a retrospective case control study to 734 patients who had 
undergone colorectal resection. The total group was assessed first. Second, the 
predictive value of outcome after surgery was assessed for malignancy (n=386), 
inflammatory bowel diseases (n=113), diverticulitis (n=91) and other indications, 
e.g. trauma, endometriosis, volvulus or ischemia (n=144). Third, all subgroups 
were assessed in relation to the setting in which surgery was performed: acute 
or elective. In patients with malignancy, the ACPGBI score was calculated as well. 
In all groups, Receiver Operating Characteristic (ROC) curves were constructed.
 
Results
POSSUM, P-POSSUM and CR-POSSUM have a significant predictive value for 
outcome after colorectal surgery. Within the total population as well as in all 
four subgroups, there is no difference in the area under the curve between the 
POSSUM, P-POSSUM and CR-POSSUM scores. In the subgroup analysis, smallest 
areas under the ROC curve are seen in operations performed for malignancy, 
which is significantly worse than for diverticulitis and in operations performed 
for other indications. For elective procedures, P-POSSUM and CR-POSSUM 
predict outcome significantly worse in patients operated for carcinoma than in 
patients with diverticulitis. In acute surgical interventions, CR-POSSUM predicts 
mortality better in diverticulitis than in patients operated for other indications. 
The ACPGBI score has a larger area under the curve than any of the 
POSSUM scores. Morbidity as predicted by POSSUM is most accurate in 
procedures for diverticulitis and worst when the indication is malignancy.          
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Conclusion
The POSSUM scores predict outcome significantly better than can be expected 
by chance alone. Regarding the indication for surgery, each POSSUM score 
predicts outcome in patients operated for diverticulitis or other indications more 
accurately than for malignancy. The ACPGBI score is found to be superior to the 
various POSSUM scores in patients who have (elective) resection of colorectal 
malignancy. 
Predictive value of POSSUM and ACPGBI scoring
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Introduction
A large number of scoring systems to assess patient’s risks of complications or death 
have been developed. The Physiological and Operative Score for enUmeration 
of Mortality and morbidity (POSSUM) was reported to be the most appropriate 
of the scores currently available for general surgical practice.(1) It uses 12 
physiological and 6 operative variables to give a calculated risk of morbidity and 
death. POSSUM was intended to be used in a comparative surgical audit. It was 
applied to a number of surgical procedures, including vascular (V-POSSUM)(2), 
oesophagogastric (O-POSSUM)(3) or colorectal (CR-POSSUM)(4) surgery.  Since 
the introduction of POSSUM in 1991 by Copeland et al. (5) Several studies have 
shown the POSSUM score to overestimate the mortality risk.(6-8) The Portsmouth 
POSSUM was proposed to improve the predictive value of the initial model and 
has been primarily validated on patients undergoing vascular surgery.(9-11)
In 2003, the Association of Coloproctology of Great Britain and Ireland (ACPGBI) 
developed its own scoring system for surgical patients with colorectal cancer. The 
ACPGBI score is supposed to be easier to use than the three POSSUM models.(12;13) 
The first aim of this study was to assess the role of POSSUM in surgical audit.
For this purpose, observed mortality and morbidity of colorectal resections 
performed in a tertiary referral center were compared with mortality and
morbidity as predicted with POSSUM, P-POSSUM and CR-POSSUM scores and
the ACPGBI score for patients operated on colorectal cancer. The second aim of 
this study was to examine the accuracy of the various POSSUM-scores
for individual risk prediction in surgery performed for malignancy, inflammatory
bowel diseases and diverticulitis.  
Methods
Inclusion
A retrospective case control study was performed of all patients older than 15 years 
undergoing colorectal resection between January 2003 and January 2008 in the 
Radboud University Nijmegen Medical Centre. Surgical interventions were performed 
in an elective or acute setting. Acute operation was defined as surgical interventions 
after emergency admission. All other operations were classified as elective. 
Data extraction
The following data were extracted from the medical records: demographics, Body 
Mass Index, coexistent morbidity, use of immunosuppressive medication, ASA 
(American Society of Anesthesiology) grade, indication and type of surgery, type 
of anastomosis, surgical re-intervention (laparotomy, not radiological drainage), 
hospital stay, POSSUM, Portsmouth-POSSUM, colorectal-POSSUM, morbidity predicted 
by POSSUM, postoperative mortality and morbidity. Morbidity was defined as an 
Chapter 2
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unexpected event within 30 days after surgery, which was harmful for the patient’s 
health and required a change of therapeutic strategy. Complications were classified 
as defined by POSSUM (http://www.sfar.org/scores2/possum2.html). Mortality was 
defined as any death within 30 days after surgical intervention. ACPGBI scores were 
calculated in patients who had colorectal resection for histological proven cancer.
POSSUM and ACPGBI
The POSSUM-score comprises a physiological and an operative component. The 
physiological score is based on 12 variables to be assessed in different grades. 
The operative severity score uses 6 variables. The definitive POSSUM-score 
is calculated with the physiological as well as the operative severity score. 
(http://www.sfar.org/scores2/possum2.html, http://www.riskprediction.org.uk/)
According to the literature on POSSUM, a normal grade was used if a variable 
was not available. The ACPGBI score, developed for oncologic resections, uses 
multifactorial logistic regression analysis to adjust for multiple risk factors, 
their interactions, and the clustering of adverse outcome. It is the result of a 
nationwide attempt in the UK to provide accurate risk adjusted outcomes involving 
over 8.000 patients from 77 centers. The ACPGBI score assesses 5 operative 
variables: age, cancer resection, ASA (American Society of Anesthesiology) 
grade, Dukes’ stage and operative urgency (http://www.riskprediction.org.uk/). 
Outcome
The (P-, CR-) POSSUM predicted mortality and morbidity was compared with the
observed mortality and morbidity. Subgroup analysis was made for operations
performed for carcinoma, inflammatory bowel disease, diverticulitis and other 
indications, e.g. trauma, endometriosis, volvulus or ischemia. 
Primary outcome was mortality. Secondary outcome measures were morbidity, 
(POSSUM-) complications and hospital stay.     
         
Statistical analysis
Receiver Operating Characteristic (ROC) curves were constructed of each group 
analyzed in order to examine sensitivity and specificity of each POSSUM score. 
Areas under the curves were compared within and between subgroups. Analysis 
of ROC curves is a widely accepted method to investigate the properties of a di-
agnostic test. The Area under the curve (AUC) measures the ability of the test to 
correctly classify those with and without a disease. Comparing the AUC in several 
subgroups and for different POSSUM scores therefore is the most appropriate 
manner to distinguish the diagnostic abilities between certain POSSUM scores in a 
specific subgroup or between subgroups for a specific POSSUM score.  
Predictive value of POSSUM and ACPGBI scoring
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Results
From January 2003 to January 2008, colorectal resection was performed in 734
patients: 385 females (52.5%) and 349 men (47.5%). The mean age was 58.4 years 
(+ 16.8; range: 16-96y). In 386 (52.5%) patients the indication for surgery was 
malignancy, in 113 (15.4%) inflammatory disease and 91 (12.4%) diverticulitis.
144 (19.6%) patients underwent colorectal surgery for other reasons: intestinal 
ischemia, volvulus, trauma, endometriosis or carcinoma of urogenital or 
gynecologic origin. The most frequent surgical procedures were resection 
of the sigmoid (23.2%) and right hemicolectomy (19.8%; Table 1).  
Chapter 2
Malignancy Inflammatory bowel 
disease
Diverticulitis Other Total
Type of surgery Elective Acute Elective Acute Elective Acute Elective Acute
n 335 51 93 20 50 41 77 67 734
Male 177 25 40 5 21 21 24 34 349
Female 158 26 53 15 29 20 53 33 385
Age (y) 65.4 64.7 40.3 42.3 58.2 58.7 49.4 58.5 58.4
(12.8)* (15.6) (14.3) (16.0) (12.0) (15.9) (15.1) (17.9) (16.8)
Body Mass 
Index
25.2 24.7 23.5 21.7 26.3 25.3 25.9 23.7 24.8
(kg/m2) (4.3) (3.7) (4.3) (3.5) (4.4) (4.0) (4.9) (2.8) (4.2)
ASA 2.1 2.2 1.9 2.2 2.0 1.9 2.1 2.7 2.1
(0.7) (0.7) (0.5) (0.8) (0.8) (0.8) (0.8) (1.0) (0.7)
Right 
hemicolectomy
99 16 5 0 0 5 7 13 145
Left 
hemicolectomy
25 6 3 1 4 0 21 5 65
Transversum 
resection
11 3 2 1 2 0 5 9 33
Ileocecal 
resection
19 5 55 15 4 5 7 11 121
Sigmoid 
resection
52 12 4 2 35 30 15 21 171
(Sub-) Total 
colectomy
35 4 17 1 1 0 6 5 69
Rectosigmoid 
resection
94 5 7 0 4 1 16 3 130
* Number in brackets is standard deviation.
Table 1. Demographics and performed procedures in the different subgroups. 
Elective operations were performed in 555 patients (74.9%), 179 (25.1%) were 
operated in an acute setting. The number of patients who had one or more  
surgical re-interventions was 152 (20.7%) (Table 2). 
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Table 2. POSSUM scores, observed mortality and morbidity, re-intervention rate and hospital stay in  
              the different subgroups.
Malignancy Inflammatory 
bowel disease
Diverticulitis Other Total
Type of surgery Elective Acute Elective Acute Elective Acute Elective Acute Elective Acute Total
n 335 51 93 20 50 41 77 67 555 179 734
Predicted mortality 
   POSSUM (%)
   P-POSSUM
   CR-POSSUM
Observed mortality 
(%)
14.5
5.4
3.9
27
(8.1)
24.6
12.2
8.7
7
(13.5)
6.7
2.3
1.3
1
(1.1)
17.3
5.7
3.0
1
(5.0)
8.8
2.8
2.1
3
(6.0)
22.0
10.8
8.4
6
(14.6)
9.3
2.9
1.6
4
(5.2)
25.5
12.4
7.9
16
(23.9)
10.7
3.7
2.5
35
(6.3)
24.4
11.2
7.7
30
(16.7)
17.0
5.9
4.0
65
(8.9)
Predictive mortality (%)
Observed mortality
(%)
50.7
130
(38.8)
64.1
18
(35.3)
29.6
32
(34.4)
45.2
10
(50.0)
35.9
18
(36.0)
58.8
16
(39.0)
35.7
32
(41.6)
64.7
33
(49.3)
40.1
212
(38.2)
61.0
77
(43.0)
46.0
289
(39.4)
Wound haemorrhage 2 2 2
Deep haemorrhage 6 3 1 1 1 1 9 4 13
Chest infection 14 6 5 2 2 1 5 3 26 12 38
Wound infection 19 7 8 1 7 4 4 7 38 19 57
Urinary infection 17 6 3 1 1 3 3 24 10 34
Deep infection 15 2 6 4 4 8 8 33 14 47
Septicaemia 9 8 1 1 3 1 4 12 17 29
Pyrexia of unknown 
origin
1 1 1
Wound dehiscence 9 1 2 2 1 4 11 8 19
Deep venous 
thrombosis and 
pulmonary embolus
6 1 1 8 8
Cardiac failure 8 2 4 1 2 2 9 10 19
Impaired renal function 3 1 1 1 1 3 4 7
Hypotension 2 1 1 2 2 4
Respiratory failure 2 3 1 1 1 2 2 4 6 10 16
Anastomotic leakage 29 5 8 1 4 2 4 9 45 17 62
Total complications 141 44 37 15 22 22 29 46 229 127 356
Re-intervention 56 11 16 5 9 10 20 25 101 51 152
Hospital stay
(median days)
(range)
10
(2-127)
11
(2-150)
8
(1-55)
7
(1-64)
9 
(3-57)
8 
(3-61)
12 
(1-59)
15
(5-132)
10
(1-127)
12
(1-150)
10
(1-150)
Morbidity was 289 / 734 (39.4%). The total number of complications amounted 356; 
so the mean number of complications per patient is 1.7. Amongst electively operated 
patients, 212 (38.2%) had one or more complications. 77 (43.0%) patients, operated 
on in an acute setting, had an unfavorable postoperative course. The most common 
complications were anastomotic leakage, surgical site infection, and pulmonary 
and urinary infections. Mean morbidity as predicted by POSSUM was 46.0% (Table 2). 
Sixty-five patients (8.9%) died within 30 days after surgery (Table 2,3). 
20
Figure 1. ROC total group.
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The predicted mortality by POSSUM was 17.0%, Portsmouth-POSSUM 5.9% and 
ColoRectal-POSSUM 4.0%. In the total population as well as the subgroups (except 
the group with patients operated for inflammatory bowel diseases) POSSUM, 
P-POSSUM and CR-POSSUM had a significant larger predictive value for outcome after 
(elective  and acute) colorectal surgery than can be expected by chance alone
(P<0.001) (Figure 1). 
  
Malignancy Inflammatory 
bowel disease
Diverticulitis Other Total
Type of surgery Elective Acute Elective Acute Elective Acute Elective Acute Elective Acute Total
Observed 
mortality
27 7 1 1 3 6 4 16 35 30 65
Respiratory 
insufficiency 
2 2 2 1 5 3 9 12
Cardiac failure 3 1 4 4
Abdominal 
sepsis
    leakage
    disease
    ischemia
5
2
2
1
1 1
1 2
1
3
2
2
6
2
2
6
5
3
12
7
5
Change of 
treatment
strategy*
7 2 1 1 3 8 6 14
Unknown 5 1 6 6
Cerebrovascular 
accident
1 1 1 1 2
Bleeding 1 1 2 2
Transfusion 
reaction
1 1 1
* Due to metastasis, progressive haematological malignancy, loss of perspective.
Table 3. Causes of mortality.
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Within the total population as well as in all four subgroups, there is no difference in 
the area under the curve between the POSSUM, P-POSSUM and CR-POSSUM scores. 
In the subgroup analysis, smallest areas under the ROC curve are seen in operations 
performed for malignancy (0.65; 0.65; 0.65) (Figure 2a, 2b, 2c, 2d).  
Figure 2a. Subgroup analysis; malignancy. Figure 2b. Subgroup analysis;                                              
                 inflammatory bowel disease.
Figure 2c. Subgroup analysis;                                              
                 diverticulitis.
Figure 2d. Subgroup analysis; other.
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This is significant worse than in the diverticulitis group (0.86, P=0.01; 0.88, 
P<0.001 and 0.89, P=0.02; respectively) and in operations performed for other 
indications (0.80, P=0.03; 0.80, P=0.03 and 0.79, P=0.03; respectively). For 
elective procedures, P-POSSUM and CR-POSSUM predictions are significantly 
worse in patients operated for carcinoma than in patients with diverticulitis 
(0.61 vs. 0.85; P=0.02 and 0.63 vs.0.89; P<0.001; respectively). For acute 
surgical interventions, CR-POSSUM predicts mortality better in diverticulitis 
than in patients operated for other indications (0.89 vs. 0.66; P=0.02). 
Within the group operated on carcinoma, 190 patients had a known histology
and the ACPGBI score was calculated (Table 4).  
The observed mortality in this group was 4.7%, morbidity 30.5%. The ACPGBI 
score predicted a mortality rate of 5.55% (+ 4.48).  
27 of the 190 performed procedures were in an acute setting (Figure 3).  
Table 4. ACPGBI score in 190 patients with carcinoma.
Carcinoma
N 190
Male : Female 108 : 82
Age (mean ± SD, range) 66 ± 12.2 (33-89) 
Effective: acute 163 : 27
ASA (mean ± SD) 2.11 ± 0.73
Observed mortality (%) 9 (4.7)
Observed morbidity (%) 58 (30.5)
ACPGBI score (mean ± SD) 5.55 ± 4.48
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The ACPGBI score, designed for oncologic colorectal resections, has a larger 
area under the curve than any of the POSSUM scores (0.854; P<0.001). 
The same applies to oncologic resections performed in the elective setting 
(P<0.001). ACPGBI was found not to be superior to POSSUM (P=0.83), P-POSSUM 
(P=0.56) and CR-POSSUM (P=0.84) in acute oncologic surgery. 14 out of 65 
patients (21.5%) died after a change in treatment policy due to extensive 
oncological disease (n=11) or the lack of perspective on an acceptable outcome 
(n=3). Morbidity as predicted by POSSUM is most accurate in procedures for 
diverticulitis (0.757) and worst when the indication is malignancy (0.532).  
Figure 3. Predictive value of ACPGBI score on outcome after colorectal resection for malignancy.
Predictive value of POSSUM and ACPGBI scoring
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Discussion
When POSSUM is applied for individual risk prediction in patients undergoing 
colorectal resections for malignancy, inflammatory bowel diseases or diverticulitis, 
the most accurate mortality predictions with any of the POSSUM scores was 
in patients with diverticulitis. The ACPGBI score is found to be superior to 
POSSUM scoring in patients who had (elective) resections of colorectal cancers.
POSSUM and surgical audit
One of the main concerns in POSSUM scoring is its overestimation of 
mortality. The mortality rate predicted by POSSUM (17.0%) was double the 
observed mortality in our total study population (8.9%). The drawbacks of 
the original POSSUM score led to the development of Portsmouth POSSUM and 
Colorectal POSSUM. In our study, both scores underestimated the mortality 
risk (5.9% and 4.0% respectively). Several reasons can be pointed out. 
First, the primary studies on POSSUM extend their analyses back to the early 1990s 
and are less likely to represent current practice.(14) Better understanding of 
diseases, improvements in diagnostic and therapeutic techniques have lowered 
mortality rates. Regarding surgical practice, developments such as laparoscopic 
intervention and enhanced recovery programs have caused a decrease 
in mortality.(15) Hence, mathematical prediction models may be outdated. 
Law et al.(16) reported over-prediction of the POSSUM scores for laparoscopic 
colorectal resections. In converted controls however, POSSUM scoring was reliable 
which implies a discrepancy in predictive value due to operative technique. 
Second, POSSUM was originally developed with patients in the United Kingdom. 
However, outcomes may vary with other countries or high volume, specialized 
centers.(17;18) Third, surgery got more and more specialized over time. The 
original POSSUM score was designed for the general surgical patient. The accuracy 
of these models is under discussion due to the use of mixed patient populations. 
More recently, several studies specify risk prediction for different subgroups.(14)
In our opinion, the main argument against the use of POSSUM in surgical audit 
is found in the validation as a risk prediction model. Nearly all reports on 
POSSUM scoring validate the score on their own series, which leads to different 
conclusions of reports regarding to over- or under predicting of the scores. Patient 
selection, local facilities and skills may be confounding factors. This is illustrated 
by a broad range of observed vs. expected ratios in the literature (Table 5). 
Chapter 2
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Author POSSUM P-POSSUM CR-POSSUM ACPGBI Mortality
POSSUM O:E* P-POSSUM O:E CR-POSSUM O:E
Malignancy
Oomen (33) 10.6 0.16 3.8 0.45 3.8 0.45 1.7
Slim (7) 13.3 0.28 5.5 0.67 3.7
Ferjani (20) 12.7 0.80 4.4 2.32 9.6 1.06 8.1 10.2
Ren (42) 5.6 0.18 2.8 0.35 4.8 0.20 1.0
Horzic (43) 6.7 1.24 7.5 1.11 8.3
Ugolini (44) 7.9 0.79 9.14 0.68 19.4 6.3
Menon (9) 15.6 0.56 8.7
Tez (30) 9.0 0.77 7.8 0.88 6.9
Bromage (28) 1.9 3.37 1.59 1.25 6.5
Ibister (45) 6.7 0.21 3.5 0.40 1.4
Poon (46) 15.0 0.75 11.3
Tan (47) 11.2 0.14 5.4 1.6
Ugolini (48) 11.2 0.92 13.1 0.79 10.3
Can (49) 13.4 0.27 5.2 0.69 3.6
Diverticulitis 
Oomen (33) 6.3 0.52 2.2 1.50 2.3 1.43 3.3
Slim (7) 6.9 0.38 2.8 0.93 2.6
Oomen (50) 7.7 0.74 5.7
Constatinides 
(32)
21.9 0.49 10.5 1.03 10.0 1.08 10.8
Table 5. Observed: expected ratios in the literature.
In our opinion, risk prediction models need to be validated to a ‘gold standard’ 
in order to allow comparative audit. Since reports on surgical outcome differ and 
definitions of adverse outcome may vary, this desired standard may be unrealistic. 
Russell(19) and Ferjani(20) have stated that a system with standard definitions 
is mandatory before clinical performance can be compared between health care 
systems and institutions. A proper and uniform definition of mortality is essential 
in risk prediction. Most studies on POSSUM describe mortality as primary outcome 
only. As Brooks et al.(6) pointed out, the majority of surgical procedures carry a low 
risk of death. However, along with decreasing mortality rates, the relevance of
predicting morbidity is increasing. POSSUM also predicts the chance that a 
patient develops one or more complications with only moderate accuracy (area 
under the curve 0.53- 0.76). Cumulative Sum Techniques (CUSUM), described 
in 1954 by Page and its first introduction in surgical practice in 1994, might 
encounter the drawbacks mentioned above. This technique allows one to judge 
whether an observed variation in performance is acceptable (i.e. probably due 
to chance) or whether the variation is greater than what could be expected from 
26
random variation and thus may be a cause for concern. However, acceptable 
and unacceptable outcome rate as Type I and II error rate has to be defined 
first. CUSUM is helpful in the evaluation of a clinical procedure before its 
implementation without the drawbacks of a randomized clinical trial. Plotting of 
cumulative sum has proved valuable for examining sequential measures, detecting 
changes over time and is applied as a means of assessing surgical skills of trainees. 
Continued surveillance using the CUSUM allows early detection of factors that 
lead to an increased failure rate. Quality control and objective and quantified 
recording of the findings meet the recommended criteria for medical audit.(21-25)
POSSUM and individual risk prediction
By tailoring POSSUM to patient- and procedure-specific assessment, it becomes a 
tool that can help to inform the individual patient on a certain procedure and the 
risk on adverse outcome. Several studies reported the value of POSSUM in surgery 
for colorectal cancer.(9; 26-30) Tekkis et al.(31) developed the colorectal POSSUM 
and differentiated for elective or acute procedures and procedures performed 
for malignancy or no malignancy. Constantinides et al.(32) studied the value of 
POSSUM scoring in patients with complicated diverticulitis and concluded that 
CR-POSSUM was more accurate to predict outcome than (P-) POSSUM.  Oomen 
et al.(33) retrospectively compared the different POSSUM scores in 241 patients 
undergoing elective resection of the sigmoid for carcinoma or diverticular disease. 
Although patients with diverticular disease had a higher score than patients 
with malignancy, mortality rate did not differ. It was concluded that none of the 
POSSUM scores was predictive of disease-specific mortality. However, we found 
significant differences in POSSUM scoring related to the indication of surgery. 
All POSSUM scores predicted outcome more accurately in patients with diverticular 
disease than in patients operated on colorectal cancer. Within the subgroup of 
patients with diverticular disease, we could not define a superior POSSUM score. 
POSSUM, P- and CR-POSSUM scores also predicted equally in patients with colorectal 
cancer. In our opinion, disease-specific patient and operative variables should be 
included to improve the scores. Furthermore, patients are getting older and pre-
existent morbidity is likely to increase. In our series, a larger variation of the 
various POSSUM scores is found in octogenarians (Figure 4). This is in accordance 
with Slim et al.(6), who studied risk prediction by POSSUM and the AFC index 
(Association Française de Chirurgie).  It is unclear whether the introduction of 
more extensive cardiac and pulmonary risk indexes might further improve 
predictive accuracy of POSSUM scoring. It may further complicate POSSUM scoring. 
The AFC index is a simpler instrument without any mathematical formulas. It 
uses only 4 independent preoperative factors and is found to be as predictive 
as P-POSSUM. 
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Malignant colorectal disease
All mean POSSUM scores were higher in the carcinoma group than 
in diverticulitis, whilst observed mortality rates were comparable. 
ACPGBI scoring was found to be superior in predicting mortality after resection 
of colorectal cancer both in elective and acute interventions, which is consistent 
with the literature.(20)(34) 37 out of 386 patients operated for colorectal 
malignancy (9.6%) had known metastasis. Mortality rate was 29.7% (11/37); all 
patients died as consequence of a change to tender loving care due to a lack of 
perspective on a reasonable outcome (Table 3). Mean POSSUM, P-POSSUM and CR-
POSSUM score in the deceased group were lower than in patients who survived 
(respectively 11.7 vs. 21.1, P=0.02; 3.9 vs. 7.8, P=0.05 and 2.5 vs. 3.6, P=0.07). 
Although based on a small population, these results demonstrate the insufficient 
predictive value of POSSUM scoring in patients with extensive oncological 
disease. Patients with colorectal cancer are likely to be immunosuppressed 
due to elderly age, nutritional status and the colorectal cancer itself. (35;36) 
The Dukes’ classification is too coarse to reflect today’s pathologists’ power to 
detect disease parameters in cancer.(33) Implementation of nutritional status 
in POSSUM might help to improve the area under the curve in malignancy.
(4,7,28) Both suggestions for improving POSSUM scoring need further research.
Question remains whether or not these patients have to be taken into account 
in validating risk prediction models. Well-informed patients with advanced cancers 
may trade off a short-term risk in exchange for cancer cure. In this population, the 
risks of resectional surgery may outweigh the benefits of a simpler and possibly 
safer palliative operation, but this requires reliable risk estimations.(13) 
Figure 4. Observed and predicted mortality related to age group.
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Inflammatory bowel diseases
No previous studies evaluated POSSUM scoring in patients with inflammatory 
bowel disease. Due to the view of the physiological variables included in POSSUM, 
the younger, relatively healthy patient with inflammatory bowel disease is likely to 
have a different score than the elderly with an extensive medical history operated 
for colorectal carcinoma. Patients with colitis often have an increased white blood 
cell count and low levels of hemoglobin or albumin, reflecting disease activity. 
Furthermore, these patients often use immunosuppressive medication and have 
a poor nutritional status, which is found to increase adverse outcome after 
surgery.(37) We found lowest POSSUM scores in this subgroup for mortality, which 
corresponded with the observed death rate. However, POSSUM underestimated 
morbidity. Younger age and the absence of cardiopulmonary comorbidity may 
explain the capability to overcome postoperative complications. POSSUM 
scoring for IBD may require a more prominent role of age, use of medication, 
nutritional status, level of hemoglobin, albumin and white blood cell count.
(28) Calibration of POSSUM for patients with inflammatory bowel disease may be 
hard, since recent review showed an improved outcome of surgery to be highly 
dependent on accurate timing of the surgery and better perioperative care. (38)
Diverticular disease
The most reliable predictions as demonstrated by the highest areas under the 
curve were found for patients with diverticulitis. The observed mortality was 
considerably higher than in patients operated for inflammatory bowel diseases 
and almost similar to patients with carcinomas. Patients with diverticulitis had 
the highest body mass indexes and were operated urgently more often, both 
associated with an increased complication rate.(39-41) Left sided resections were 
more frequent performed in patients with diverticular disease (81.3%) than in 
malignancy (50.3%) and inflammatory bowel diseases (15%). Left sided resections 
are known to cause more complications.(37) Another explanation may be patient 
selection. High-risk patients with diverticular disease may be withheld from 
surgery, whereas a malignant indication for surgery will not allow a conservative 
treatment strategy. Accurate definition of high-risk patients is essential. Body 
mass index, operative urgency and degree of peritoneal contamination may 
be important variables in order to calibrate POSSUM scoring for diverticulitis. 
This study questions the role of POSSUM for comparison of clinical 
performance between health care institutes. Poor definitions of surgical 
outcome and problematic validation of this risk prediction model are the 
main objections to use POSSUM for surgical audit. In its present form, POSSUM 
scoring should not be used for medical decision making in individual patients 
either. Future investigation needs to point out if further calibration of 
POSSUM is feasible, or that alternative risk prediction models need to be 
developed. One solution may be for models to be more disease specific. 
Chapter 2
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Abstract
Background
Enhanced Recovery After Surgery (ERAS) programs are associated with reduced 
hospital, morbidity and mortality. The aim of the present study was to 
evaluate whether the introduction of ERAS care improved the adverse events 
in colorectal surgery. In a cohort study mortality, morbidity and length of stay 
were compared between ERAS patients and carefully matched historical controls.
Methods
Patients were matched for their type of disease, the type of surgery, (P-, CR-) 
POSSUM score, gender and American Society of Anesthesiologists (ASA) grade. 
The primary outcome measures of this study were mortality and morbidity. 
Secondary outcome measures were fluid intake, length of hospital stay, the number 
of re-laparotomies and the number of readmissions within 30 days. Data on the
ERAS patients were collected prospectively. 
Results
Sixty-one patients treated according to the ERAS program were compared with 
122 patients who received conventional postoperative care. The two groups 
were comparable with respect to age, ASA grade, (P-, CR-) POSSUM score, type 
of surgery, stoma formation, type of disease and gender. Morbidity was lower in 
the ERAS group compared to the control group (14.8 % versus 33.6% respectively; 
P=<0.01). Patients in the ERAS group received significantly less fluid and spent 
fewer days in the hospital (median 6 days; range 3-50 vs. median 9 days; range 
3-138; P= 0.032). There was no difference between the ERAS and the control group 
for mortality (0 vs. 1.6%; P=0.55) and readmission rate (3.3 vs. 1.6%; P= 0.60).
Conclusion
Enhanced Recovery After Surgery program reduces morbidity and the length of 
hospital stay for patients undergoing elective colonic or rectal surgery.  
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Introduction
Colorectal resections are associated with an in-hospital stay of 6 to 11 days 
and a complication rate of 15% to 20%. ‘Fast-track’ or enhanced recovery 
programs are developed to improve perioperative care in these patients.(1-3) 
ERAS (Enhanced Recovery After Surgery) protocols aim at reducing the surgical 
stress response and optimizing recovery, thus reducing the length of hospital stay. 
All elements in ERAS separately have been shown to improve patient outcome. 
Preoperative education about the ERAS program diminishes anxiety and is 
associated with an earlier return of gastro-intestinal motility after surgery.(4) 
Pre-operative carbohydrate loading is associated with earlier return of gastro-
intestinal motility and a significantly shorter hospital stay.(5) Colonic lavages are 
associated with patient discomfort and electrolyte disturbances and can safely 
be avoided in elective colonic surgery.(6-10) Epidural analgesia provides better 
treatment of postoperative pain and leads to an earlier gastro-intestinal motility.
(11;12) Hypotension, a common physiologic side effect of epidural analgesia, 
can be treated safely with a vasopressor.(13) Post-operative pain relief is best 
managed without opioid analgesia because of the adverse effects it has on the 
central nervous system, respiratory function and gastrointestinal function.(14) 
Intraoperative fluid management aiming at a zero balance reduces the number 
of patients who experience morbidity and shortens the time to recovery 
of gastro-intestinal motility and reduces hospital stay.(15;16) Early post-
operative enteral feeding shows a reduction in the risk of postoperative 
complications, hospital stay and mortality.(17) Bed rest after surgery is 
undesirable because it impairs pulmonary function, tissue oxygenation and 
predisposes to pulmonary complications.(18) To avoid this, mobilizing patients 
as soon as possible is an important factor in improving postoperative care. 
The aim of the present study was to compare mortality, morbidity and 
in-hospital stay in a cohort of carefully matched patients receiving conventional
postoperative care and the ERAS program to evaluate the clinical relevance 
of the improved perioperative care. 
Methods
Identification of patients
A cohort of consecutive patients that underwent elective open colonic or rectal 
resection following the ERAS regime was compared with a matched historical 
cohort who underwent colonic or rectal resection with conventional perioperative 
care. Between May 2006 and July 2008 patients, who were above 18 years of 
age and were scheduled for any colonic or rectal resection and had an American 
Society of Anesthesiologists (ASA) grade of 1-3, were treated according to an ERAS 
program. In all patients a colorectal resection was performed, with or without 
primary anastomosis. A loop ileostomy was created in any low rectal anastomosis 
and in patients with a high estimated risk to develop anastomotic leakage. 
ERAS versus conventional postoperative care in colorectal surgery
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Running two protocols of postoperative care in one surgical ward would be 
prone to bias in a randomized trial. For this reason a matched cohort study was 
performed. Since all eligible patients operated in the time-span mentioned above 
received ERAS, a historical control group was used, composed of patients that 
would have been eligible for ERAS in the successive period. Patients in the control 
group were operated from January 2003 to May 2006. The latter group was obtained 
from a surgical database. The same team of surgeons performed all procedures.
Each patient from the ERAS group was matched with two patients from the control 
group on age, gender, (P-, CR-) POSSUM score (Physiological and Operative Score 
for enUmeration of Mortality and morbidity), American Society of Anesthesiologists 
(ASA) grade, type of disease and surgical procedure.    
Criteria of exclusion
Patients with an ASA grade 4-5 and younger than 18 years were excluded 
from analysis.
ERAS protocol
In the outpatient clinic, patients who were treated according to the ERAS protocol 
were informed about the operative procedure and rehabilitation program. 
Before surgery, patients were consulted by an anesthesiologist and if necessary 
by a dietitian. All patients were admitted the day before surgery and could eat 
until midnight, including four drinks of carbohydrate (PreOP®, Nutricia; Numico, 
Zoetermeer, the Netherlands). Patients could drink water freely until 2 hours 
before surgery. Two hours before surgery patients received two drinks of PreOP®. 
In the case of a planned left sided resection, a phosphate enema was given the 
evening before and on the day of surgery. Thrombotic prophylaxis (nadroparin 
2850 IE) was started the day before surgery. Antibiotic prophylaxis (cefazolin 2 g 
and metronidazole 500 mg intravenously) was given 30 minutes before incision. A 
transverse incision was preferred, except in Crohn’s disease and rectal surgery. 
In order to maintain a normothermic body temperature, the temperature in the 
operating theatre was increased to 22 degrees Celsius and a bair hugger and warmed 
intravenous fluids were applied. Anesthesia consisted of a combination of epidural 
analgesia and general anesthesia. Before the induction of anesthesia, an epidural 
catheter was inserted at level Th7/8. After the confirmation of proper placement by 
a test dose (Lignocaine 2% 3 ml), bolus infusion of 4 ml sufentanil produced sufficient 
analgesia for the first 30 minutes of surgery. Afterwards, repeated bolus infusion of 
2-3 ml bupivacaine 0.5 % maintained the operative analgesia. No additional opioids 
were given intravenously. At the end of surgery, continuous epidural infusion 
of 6 ml/hour of ropivacain 0.2% with 1 microgram/ml sufentanil was started 
for postoperative analgesia. This infusion lasted for two days postoperatively.
During and after surgery, hypotension was preferably treated with a 
vasopressor agent (ephedrine 5 mg or phenylefrine 0,1 mg) instead of 
intravenous fluid bolus in order to maintain a neutral fluid balance throughout 
the perioperative period. No drains were used except in rectal surgery and
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the nasogastric tubes were removed immediately after surgery. To prevent
post-operative nausea and vomiting 4 mg ondansetron was administered
intravenously at the end of surgery. After surgery the patient was allowed to drink 
water and, if tolerated, patients received two drinks of PreOP®. On postoperative 
day 1, patients were offered a normal diet. Intravenous fluid administration aimed 
at a urine production of at least 0.5 ml/kg and the total fluid intake should not exceed 
2 liter/24h. Fluid balances were recorded daily. A structured mobilization program 
was also included in the ERAS protocol. Patients were encouraged to sit out of bed on 
the day of surgery and to walk the length of the ward on the first postoperative day. 
The inserted urinary catheter was removed at the same time as the thoracic epidural 
catheter. Subsequently, pain was managed with paracetamol and nonsteroidal 
anti-inflammatory drugs. The use of oral opioid analgesics was limited to relieve 
breakthrough pain. Each protocol item and any deviation from the protocol were 
noted on a bedside checklist. Discharge criteria were: adequate pain relief on non-
opioid oral analgesia, normal food intake and return to preoperative mobility level. 
Conventional postoperative care protocol
The perioperative care, before the ERAS program was implemented, was 
according to the surgeon’s preference. Thrombotic and antibiotic prophylaxis was 
given and the practice of bowel preparation was largely abandoned. Discharge 
criteria were identical to the ERAS-era. 
Data extraction 
After retrieving all reports and information from paper and electronic patient 
files, the following data were extracted: sex, age, indication for surgery, type 
of surgery, ASA grade, POSSUM score, P-POSSUM score, CR-POSSUM score, 
stoma formation, type of medication, oral and intravenous fluid intake, urinary 
output, stoma production, nasogastric tube production, length of stay in the  
hospital, number of readmissions, complication and mortality rate. In the ERAS
group additional data were prospectively collected: first day of defecation, 
length of epidural analgesia, first day of mobilisation and the number of days  
that oral analgesia was used.        
Outcome measures
The primary outcome measures were mortality and morbidity. Mortality was 
defined as death within 30 days after surgery. A complication was defined as an 
unfavorable postoperative course with the need for an intervention to prevent 
further harm, according to the definition of the Dutch Association of Surgeons. 
Individual complications were defined as stated in Table 1. Secondary outcome 
measures were fluid intake, reinsertion of nasogastric tubes, number of 
re-laparotomies, length of hospital stay and number of readmissions within 30 days. 
ERAS versus conventional postoperative care in colorectal surgery
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Analysis
The analysis was by intention-to-treat principles. No patients were excluded for
reasons of protocol violations. Statistical analyses were performed with SPSS® 
version 16.0 (SPSS, Inc., Chicago IL) for Windows® and STATS direct® (Altrinchem, 
UK). Medians and ranges or means and standard deviations are presented for all 
continuous outcome measures. Comparisons between the ERAS and conventional 
postoperative care group were made using the chi-square test for binary outcomes 
and the student’s t-test was used for continuous outcomes. Non-parametric 
tests were carried out to calculate statistical differences in POSSUM scores.
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Surgical complications
Wound hemorrhage local hematoma requiring evacuation
Deep haemorrhage postoperative bleeding requiring re-exploration
Burst abdomen deep wound breakdown, requiring surgical closure of the abdominal wall
Deep infection the presence of an intra-abdominal collection confirmed clinically or 
radiologically
Anastomotic leak discharge of bowel content via the drain, wound or abnormal orifice
Wound infection wound cellulitis or the discharge of purulent exudate and the necessity 
of opening the wound
Medical complications
Chest infection production of purulent sputum with positive bacteriological cultures, 
with or without chest radiography changes or pyrexia, or consolidation 
seen on chest radiograph
Urinary infection the presence of > 105 bacteria / ml with the presence of white cells in 
the urine, in previously clear urine
Septicaemia positive blood culture
Pyrexia of unknown 
origin
any temperature above 37° C for more than 24 h occurring after the 
original pyrexia following surgery (if present) had settled, for which no 
obvious cause could be found
Deep venous throm-
bosis and pulmonary 
embolus
when suspected, confirmed radiologically by venography or ventilation / 
perfusion scanning or diagnosed at post mortem
Cardiac failure symptoms or signs of left ventricular or congestive cardiac failure 
(alteration from preoperative measures)
Impaired renal function symptoms or signs of left ventricular or congestive cardiac failure (al-
teration from preoperative measures)
Hypotension a fall in systolic blood pressure below 90 mmHg for more than 2 hours 
as determined by sphygmomanometry or arterial pressure transducer 
measurement
Respiratory failure respiratory difficulty requiring emergency ventilation
Table 1. Definitions of separate complications.
* Complications had to occur within 30 days after surgery.
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Results
Sixty-one patients, treated according to the ERAS program, were matched with  
122 historical controls that had conventional postoperative care. The two  
groups were similar with respect to age, ASA grade, (P-, CR-) POSSUM score, 
type of surgery, stoma formation and type of disease (Table 2).  
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Table 2. Patient characteristics and types of surgery.
ERAS (%) 
(n=61)
Control (%) 
(n=122)
P-Value
Characteristic
Male * 36.1 (n=22) 50.8 (n=62) 0.06
Female * 63.9 (n=39) 49.2 (n=60)
Age (years) * 57 (17.6) 60 (17.4) 0.39
POSSUM ** 7.50 (6.1) 8.37 (6.7) 0.37
P-POSSUM ** 2.59 (2.9) 2.57 (2.8) 0.92
CR-POSSUM ** 2.75 (3.2) 2.79 (3.2) 0.93
Stoma formation * 11.5 (n=7) 9.0 (n=11) 0.60
Type of surgery *     0.95 ***
Ileocecal resection 21.3 (n=13) 19.7 (n=24)
Right hemicolectomy 37.7 (n=23) 39.3 (n=48)
Left hemicolectomy/ 
resection of sigmoid
3.3 (n=2) 3.3 (n=4)
(Low) anterior resection 24.6 (n=15) 24.6 (n=30)
Subtotal colectomy 13.1 (n=8) 13.1 (n=16)
Type of disease *
Cancer 75.4 (n=46) 77.1 (n=94)    0.83 ***
IBD 23.0 (n=14) 21.3 (n=26)
Diverticulitis 1.6 (n=1)
ASA grade *
1 29.5 (n=18) 25.4 (n=31)    0.1 ***
2 59.0 (n=36) 53.3 (n=65)
3 11.5 (n=7) 21.3 (n=26)
*  The first number is the percentage and the number in between the brackets is the absolute number
** The first number is the mean and the number in between brackets is the standard deviation
*** These P-values represent the overall similarity of the two groups in these characteristics
Females were slightly overrepresented in the ERAS population (63.9 vs. 36.1%; 
P=0.06). 57 patients (93%) who were treated in the ERAS group had an epidural 
catheter until the second postoperative day (median; range:1-4). 4 patients 
in whom placing the epidural catheter could not be realized received a 
PCA-pump. Patients were mobilized out of bed on the first postoperative 
day (median; range: 0-3).     
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The stools were passed on day 3 (median; range: 0-11) versus 4 days 
(median; range 1-8) in the control group. NSAIDs were used until day 4 
(median; range: 0-15). Paracetamol was used until day 6 (median; range: 
0-40). In the control group 77 patients had epidural anesthesia (63%).
The morbidity rate was higher in the control group than in the ERAS group (33.6 
% vs. 14.8 %; P<0.01). Total number of complications amounted 63 in the control 
group versus 12 in the ERAS group (P=<0.01). Corrected for gender, the control 
group had a 3.4 times higher risk to develop an unfavorable postoperative course 
than the ERAS group. Individual complications were similar in both groups, except 
for urinary tract infections. None of the patients in the ERAS group developed a 
urinary tract infection versus 6.6% of the patients in the control group (P=0.05). 
Septicemia occurred in none of the patients in the ERAS group, the incidence 
was 3.3% in the control group (P=0.30). 4.9% of the patients in the ERAS group 
developed a wound infection versus 11.5% of the patients in the control group 
(P=0.18). In the control group, 6.6% of the patients developed a deep surgical site 
infection. For ERAS this amounted 1.6% (P=0.28). Anastomotic leakage occurred 
more often in patients who had conventional postoperative care (7.4% vs. 3.3% 
(P=0.34). A dehiscence of all layers of the abdominal wall was seen in 1.6% in the 
ERAS group and in 4.1% of the patients in the control group (P=0.67) (Table 3).
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ERAS 
%; (n) 
Standard care 
%; (n)  
P-Value
Surgical complications*
Wound hemorrhage 0 0
Deep haemorrhage 4.9 (3) 0.8 (1) 0.11
Anastomotic leak 3.3 (2) 7.4 (9) 0.34
Wound infection 4.9 (3) 11.5 (14) 0.18
Deep infection 1.6 (1) 6.6 (8) 0.28
Burst abdomen 1.6 (1) 4.1 (5) 0.67
Medical complications*
DVT / embolus 0 0
Chest infection 1.6 (1) 4.1 (5) 0.67
Cardiac failure 0 (0) 2.5 (3) 0.55
Urinary infection 0 (0) 6.6 (8) 0.05
Septicaemia 0 (0) 3.3 (4) 0.30
Pyrexia of unknown origin 0 (0) 0 (0)
Impaired renal function 0 (0) 2.5 (3) 0.55
Hypotension 0 (0) 0 (0)
Respiratory failure 1.6 (1) 2.5 (3) 0.99
Total number of complications ** 12 63 0.0001
Patients with complication(s) 14.8 (9) 33.6 (41) 0.008
Table 3. Morbidity rates in the ERAS and control group.
*  The first number is the percentage and the number in between the brackets is the absolute number
** Only the absolute number is shown
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No patient died in the ERAS group within 30 days after surgery. Two patients 
in the control group died (1.6%; P=0.55). One patient developed congestive 
heart failure after fluid resuscitation for hypotension. Eight days later she 
became septicaemic, a laparotomy was carried out and bowel ischemia 
was found. The other patient also received an excess of fluid because of 
her low urine output and low fluid intake. Nevertheless, her renal function 
deteriorated. Four days later she also developed fatal heart failure. 
Patients receiving ERAS postoperative care, were administered significantly 
less intravenous fluid during (day of) surgery and day 1 till 5 postoperative 
(P<0.001). Oral intake was higher than in the control group on day of, first and 
second day postoperative (P< 0.001). This led to a larger urinary production 
on the first three postoperative days in the control group (P<0.05). Total fluid 
intake was higher in the second and third postoperative day (p<0.05) (Figure 1-4).
Reinsertion of nasogastric tubes was similar in both populations (P=0.85; Table 
4). Patients treated according to the ERAS regime spent significantly fewer 
days in the hospital (median 6; range 3-50) than the control group (median 9; 
range 3-138; P= 0.032). The number of readmissions was similar in both groups
(3.3% ERAS vs. 1.6% control; P=0.60) (Table 4).  
ERAS versus conventional postoperative care in colorectal surgery
Figure 1. Intravenous fluid intake (ml/day). Figure 2. Oral fluid intake (ml/day).
Figure 3. Total fluid intake (ml/day). Figure 4. Urinary fluid intake (ml/day).
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*  The first number is the percentage and the number in between the brackets is the absolute number
** The first number is median and the number in brackets in range
Two patients in the ERAS group were readmitted with surgical site infections. One 
developed a presacral abscess, which was drained transrectally. The other patient 
developed a wound abscess, which was incised and drained. One patient in the control 
group developed an intra-abdominal abscess, which was treated conservatively. 
The other patient had successful conservative treatment for a gastro paresis. 
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ERAS 
%; (n) 
Standard care 
%; (n)  
P-Value
Mortality* 0 (0) 1.6 (2) 0.55
Number of reinserted nasogastric tubes* 19.7 (12) 21.3 (26) 0.85
Time to first defecation (days)• 3 (0-11) 4 (1-8)
Length of hospital stay  (days)• 6 (3-50) 9 (3-138) 0.021
Number of readmissions* 3.3 (2) 1.6 (2) 0.60
Number of re-laparotomies* 14.8 (9) 17.2 (21) 0.83
Burst abdomen 1.6 (1) 4.1 (5) 0.67
Table 4. Mortality and secondary outcomes of the patients in the ERAS and control group.
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Discussion 
The results of this study suggest that the Enhanced Recovery After Surgery 
program is superior to conventional postoperative care for patients undergoing 
elective colonic or rectal resection. Patients treated according to an ERAS 
program develop significantly less complications and are shorter hospitalized. 
This study is a historic cohort study with carefully matched controls. The control 
group was chosen from years prior to the introduction of the ERAS program. 
Because the discharge criteria were identical in both groups further reduction 
of bias was achieved. Observer bias was avoided, though awareness about early 
recovery may have influenced decisions on early discharge. On the other hand, 
data in the ERAS group were collected prospectively. The historic nature of the 
control group is likely to have caused the underreporting of complications, thus 
leading to an underestimation of the beneficial effect of ERAS. Since patients in 
both groups were operated by the same team of surgeons, selection bias is thought 
to be small. A randomized trial on ERAS is difficult to perform, because running 
traditional and ERAS care simultaneously carries the risk of mixing elements of 
both regimens. Blinding of nursing and medical staff would be impossible. 
To overcome these flaws, the design of such a study is challenging. In our study, 
patients were carefully matched.  Females were slightly overrepresented in 
the ERAS group (p=0.06). Literature states male gender predisposes to an increased 
incidence of anastomotic leakage after colorectal surgery. One of the main theories 
is the higher levels of estrogens in females and anatomical differences of the 
pelvis.(19) Further analysis of the data excluded gender as a risk factor 
for the development of complications. There was less ASA 3 in the ERAS
population (not significant). After excluding ASA 3 patients from analysis,  
significant differences in total number of complications and number of patients
with one or more adverse events persisted. In this study, the targets 
of ERAS were met. All ERAS patients were informed in a standardized way in 
the outpatient clinic. They received a daily perioperative schedule. Patients 
knew what was expected and allowed. In the conventional group, it is likely 
information was not uniform due to variance in information between the 
individual surgeons. Second, all patients of ERAS received preoperative 
carbohydrate loading where none of the conventional treated patients had 
Pre-Op. Since it was policy not to apply colonic lavages before the ERAS era, there 
was no difference between both groups. Epidural use was good practice in the 
conventional group, however, in the ERAS protocol it was one of the key elements. 
This led to a higher epidural use in the ERAS population (93 vs. 63% respectively; 
P<0.001). Epidural analgesia, one of the main issues in fast track protocols, 
has been suggested to provide an optimal pain relief, thus reducing surgical 
stress response and may reduce postoperative morbidity and mortality.(3,12,20) 
Rodgers et al.(20) found a significant reduction in deep vein thrombosis, pulmonary 
embolism, transfusion requirements, pneumonia, other infections and respiratory 
depression in patients with neuroaxial blockade. It is likely that this difference 
contributes to a reduced complication rate in ERAS. Patients in the ERAS group
received less fluid intravenously and started drinking sooner after surgery. 
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Total fluid intake and urinary production was higher in the control group. In our 
findings, morbidity was higher in the control group. Excessive fluid administration is 
thought to contribute to an increased complication rate.(16,21-23) It is important 
to realize more elements than mentioned above may contribute to improved 
outcome: the use of short-acting and oral anaesthetics and prokinetics, lack of 
premedication and nasogastric tubes, early removal of catheters and drains, 
minimal length incisions, early mobilization and the preservation of 
normothermia.(3)      
It is likely that the combination of elements in ERAS favoured uncomplicated 
outcome after colorectal surgery. Mortality did not differ between both 
groups. Two patients (83 and 85 years old) in the control group died because 
of cardiac complications. Patients in the control group had an almost 
three-fold risk to develop one or more complications. Individual complications 
failed to reach significance. Since data collection in the historic group 
could lead to underreporting of minor complications, this is less likely for major
complications, e.g. anastomotic leakage, surgical site infections and burst
abdomen failed significance. All, however, tend to be more frequent in
the conventional care group. Although this ERAS program is evidence-based, 
some improvements can be made. Recent evidence suggests that perioperative 
supplemental oxygen administration reduces the incidence of surgical wound 
infections.(24) It exposes the patient to little or no risks, has little associated 
costs while it reduces the incidence of wound infections by half.(25) The 
addition of specialized nutritional products to the standard carbohydrate drinks, 
offered to patients in the used ERAS program, also shows promising results 
towards reducing complications after gastro-intestinal surgical procedures. 
The specialized nutritional products are the amino acids arginine and 
glutamine, omega-3 fatty acids and nucleotides in the form of RNA. 
Wound infections, anastomotic leakage, abdominal abscesses and pneumonia
were significantly reduced. (26)   
Patients who were treated according to the ERAS program spent significantly 
less time in the hospital. This did not result in more readmissions that reflect 
early recovery, probably due to a more favorable postoperative course. 
Besides, this implies benefit for the hospital resources because with the 
implementation of the ERAS program a higher level of cost-effectiveness 
can be reached. 
This study demonstrates that the program as a whole is clearly beneficial and 
not flawed with unexpected negative effects. Epidural analgesia and a restricted 
fluid administration are thought to be the main contributing factors to a 
favorable outcome. More research is necessary to optimize perioperative care.
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Abstract
Background 
Enhanced Recovery After Surgery programs have been developed to improve 
recovery, shorten hospital stay and reduce morbidity. 
Objective
The aim of the current study is to examine the effects of the enhanced recovery 
program on the outcome of rectal surgery. 
Design
A cohort of patients that underwent open rectal surgery following an enhanced 
recovery program was compared with a historical case matched control group receiving
conventional perioperative care. Patients were matched for type of surgery, disease, 
comorbidity and demographic characteristics. Data regarding fast track targets, 
length of hospital stay, mortality, complications, re-laparotomies and readmissions 
were collected. 
Results 
Forty-one patients in the enhanced recovery group were compared with eighty-
two case-matched patients receiving conventional care. The length of hospital 
stay (median 8 days versus 12 days, P<0.005) was reduced in the ERAS group. 
There were no significant differences in epidural use, mortality, morbidity and 
readmission rates.
Limitations
This study performed an intention to treat analysis for the multi-modal enhanced 
recovery program in rectal surgery. Specific elements of the program were 
not analyzed separately. The study used nonrandomized historic controls for 
comparison.   
Conclusion 
Enhanced recovery programs help to reduce hospital stay after rectal surgery. 
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Background 
Traditionally, colorectal surgery has been associated with long recovery 
periods and a hospital stay of 1 to 2 weeks. Complication rates of 15-
20% and up to 45-48% have been described.(1,2) Over the past decade, 
several traditional perioperative practices were shown to be outdated. 
Fast-track or Enhanced Recovery After Surgery (ERAS) programs have been 
designed to improve recovery, shorten hospital stay and reduce morbidity, 
without changing readmission rates and mortality. Moreover, ERAS has 
provided better control of postoperative pain, faster rehabilitation 
and return of gut function. (3-17) We  confirmed these findings in 
our previous study concerning colorectal surgery in general.(18)
Rectal surgery is associated with higher complication rates and longer hospital 
stay compared to colonic surgery.(16) Moreover, some items in the ERAS 
program, like the thoracic epidural, may need adjustment for rectal surgery, 
potentially eliciting different effects on recovery. Until this date, little is 
known about the value of enhanced recovery programs on rectal surgery. 
The aim of the current study is to examine the effects of the Enhanced 
Recovery After Surgery program focusing exclusively on rectal surgery.
Materials and Methods
A consecutive series of patients from the Radboud University Nijmegen Medical 
Centre (Nijmegen, the Netherlands) that underwent open elective rectal 
surgery received perioperative care according to the ERAS protocol. The 
matched historical control group received conventional perioperative care.
Patients aged 18 years or above, American Society of Anesthesiologists (ASA) grade 
I-III, who received this type of surgery between January 2008 and December 2009 
were included. Cases undergoing multiorgan resections and emergency surgery 
were excluded. All patients were treated according to the ERAS protocol and 
underwent rectal surgery via laparotomy, with or without primary anastomosis. 
Like a previous study from this institution that examined ERAS care for 
general colonic resections(18), a matched cohort study was carried out. 
Matched controls were identified through an electronic database search 
for patients operated in our hospital between February 2000 and April 
2006 (i.e. before the introduction of the ERAS program), who would have 
met the same in- and exclusion criteria for ERAS as mentioned above.
Each patient from the ERAS group was carefully matched with two patients from 
the historical control group for age, gender, type of surgery, type of disease, 
ASA grade, age and Colorectal Physiologic and Operative Severity Score for the 
enUmeration of Mortality (CR-POSSUM) score. All procedures were performed 
according to the same technical operation protocols and operating team in 
the Radboud University Nijmegen Medical Centre, a tertiary referral center.
ERAS versus conventional perioperative care in rectal surgery
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ERAS protocol
All patients in the ERAS group were cared for according to the enhanced recovery 
protocol as described previously(18), including preoperative patient teaching, 
carbohydrate supplements, thoracic epidural anesthesia and a restricted fluid 
regimen. Nasogastric tubes were removed directly after surgery. Peroperative 
intravenous fluid administration was based on calculated insensible loss aiming at 
a maximum fluid balance of + 500 mL. Suprapubic urinary drainage was standard in 
rectal resections since most patients had epidural anesthesia and urinary function 
may be impaired after rectal surgery and to prevent urinary tract infections. Oral 
fluid intake was resumed on the day of surgery and normal diet started as soon 
as tolerated. Normal diet was defined as: the eating of solid food in any desired 
quantity and without restrictions to the composition of the food or the way of 
preparation. Patients followed a mobilization program starting on the day of 
surgery. Sitting at the edge of the bed was encouraged on the day of operation 
and patients were stimulated walking on the corridor of the ward on the first 
postoperative day. In case of impaired mobility, regaining the preoperative mobility 
level was attempted on the first postoperative day. Postoperative analgesia was by 
patient controlled epidural infusion of Ropivacain (0.2%; 6 ml/h) and Sufentanyl 
(1 µg/ ml) for the first two days after the operation. Paracetamol and nonsteroidal 
anti-inflammatory drugs (Naproxen 2x 500 mg or Diclofenac 3x 50 mg) were given 
along with solid food. Opioid analgesics were used as escape analgesia only.
Patients were considered fit for discharge when they had an adequate oral intake, 
had returned to their preoperative mobility level and were free of opioids or 
parenteral medication.
Conventional care protocol
Before the ERAS protocol was introduced in our hospital, patients received 
traditional perioperative care according to the surgeon’s preference. Thrombotic 
and antibiotic prophylaxes were given and the practice of bowel preparation had 
already been abandoned. Discharge criteria were identical to the present ERAS 
protocol.
Data extraction
Data on ERAS patients were collected prospectively during admission. The 
doctor of the ward, responsible for daily visits and all patient examinations, 
collected data. Data were recorded on a case report form that was part of 
the daily notes in the patient file. The discharge letter was composed from 
this CRF in an automated fashion and used to extract data for further analysis 
in Excel and SPSS. Historical control group data were obtained from electronic 
and paper medical records. The collected variables are summarized in Table 1.
Chapter 4
55
Outcome measures
Outcome measures were length of hospital stay (LOS), mortality, complications, 
re-laparotomies and readmissions. Complications were classified as described 
before.(18) Complications and re-laparotomies were registered if taking place 
within 30 days after surgery or during (re-) hospitalization. Readmissions 
within 30 days after discharge were defined as surgery-related. Total LOS 
was classified as time hospitalized including days during any readmission.
Statistical analysis
Postoperative length of stay is an overall surrogate outcome measure reflecting 
recovery and the occurrence of complications. Based on previous data considering 
postoperative hospital stay after colorectal surgery in this institution, a 
sample size calculation showed that, using double controls, a minimum of 38 
patients would be required in the ERAS group to demonstrate a significant 
reduction (P<0.05) in length of stay of 3 days with a power of 85 per cent.(18) 
Analysis was according to intention-to-treat principles. Results were 
analyzed using SPSS® (SPSS Inc, Chicago, Illinois) for Windows® version 16.0. 
Comparisons between the ERAS and control group were made using chi-square tests 
and Fisher’s exact tests for all categorical variables, and Mann-Whitney U tests 
and t-tests for continuous variables. P values < 0.05 were considered statistically 
significant.        
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Table 1. Collected data*.
* Data on ERAS patients were collected prospectively. Historical control group data were obtained 
from electronic and paper medical records.
Surgical complications Pre-/intraoperative variables Postoperative variables
Low anterior resection Sex Complication
Abdominoperineal resection Age Length of hospital stay
Indication for surgery Re-laparotomies
ASA grade Readmissions
CR-POSSUM score In-hospital mortality
Body mass index (BMI) Compliance:
Neoadjuvant therapy - First day of mobilization; 
  oral fluids; solid food
  defecation
Medication use - Day of stopping intravenous           
  fluids; epidural analgesia
Type of surgery - Number of days oral 
  analgesia was used
Stoma and/or anastomosis 
formation
Level of epidural catheter
Intraoperative fluid balance
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Results 
Matching all patients in the ERAS group with historical cases resulted in similar 
patients in the study (n=41) and control (n=82) group. No significant differences 
were found regarding age, sex, ASA grade, BMI, CR-POSSUM score, operation 
indication and type of surgery (Table 2). 
ERAS (n=41) Control (n=82) P
Age (years) 1 66.41 ± 11.62 63.39 ± 11.40 0.171 3
Sex 2
  Male 65.9 (27) 59.8 (49) 0.5120 4
  Female 34.1 (14) 40.2 (33)
ASA 2
  I 26.8 (11) 23.2 (19) 0.589 4
  II 41.5 (17) 51.2 (42)
  III 31.7 (13) 25.6 (21)
BMI 1 25.55 ± 4.41 24.53 ± 3.61 0.173 3
CR-POSSUM (range 0.3-95.3) 1 10.09 ± 10.82 8.42 ± 8.83 0.353 3
  Physiology (range 6-16) 9.22 ± 2.56 8.55 ± 2.28 0.143 3
  Operative severity (range 4-22) 11.41 ± 0.59 11.72 ± 0.59 0.008 3
Operation 2
  Low anterior resection 53.7 (22) 53.7 (44) 1.000 4
    diagnosis cancer 90.9 (20) 90.9 (40)
  Abdominoperineal resection 46.3 (19) 46.3 (38)
    diagnosis cancer 100 (19) 100 (38)
First laparotomy 2 70.7 (29) 59.8 (49) 0.234 4
Anastomosis 2 41.5 (17) 45.1 (37) 0.700 4
Stoma formation 2 87.8 (36) 74.4 (61) 0.086 4
Epidural anesthesia 2 85.4 (35) 78.0 (64) 0.334 4
Neoadjuvant radiotherapy 2
  5x5 Gy 34.1 (14) 29.6 (24) 0.583 4
  25x2 Gy ± chemo 31.7 (13) 26.8 (22)
  None 34.1 (14) 43.9 (36)
1 Values are means ± standard deviation
2 Percentages with absolute numbers in parenthesis 
3 t-test
4 chi square test 
ASA: American Society of Anesthesiologists; BMI: Body Mass Index; CR-POSSUM: Colorectal Physiologic 
and Operative Severity Score for the enUmeration of Mortality; IBD: Inflammatory Bowel Disease.
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Stoma and anastomosis formation, prior laparotomies and type of anesthesia 
were similar in both groups. Most patients were operated on for cancer. There 
was no significant difference between the study group and the matched historic 
controls regarding use of neoadjuvant treatment in general and of chemo radiation
in particular. The evaluation of adherence to the protocol showed a considerable 
shift of techniques applied. 80.5 percent of patients received epidural anesthesia. 
There was no difference in the use of epidural anesthesia between ERAS patients 
(85.4%) and controls (78.0%) (P=0.334). The epidural catheter was placed in the 
thoracic region in 73.2% of ERAS patients versus 50.0% in controls (P< 0.001). 
Lumbar epidural was used as an adjustment of technique to meet the anticipated 
needs of rectal surgery patients in 11.9% of ERAS patients versus 28.0% of historic 
controls (P<0.05). General anaesthesia without (adequate) epidural catheter was 
used in 14.6% of the ERAS patients vs. 22.0% in the control group (not significant). 
Peroperative fluid balances appeared to be less positive in ERAS (not significant). 
No significant difference was found between groups in the use of separate types 
of analgesics. Both opioids and non-steroidal anti-inflammatory drugs were 
used in similar percentages of patients with comparable periods of time.  
Paracetamol use was comparable in both populations, but duration of use in the 
ERAS group was shorter. In the ERAS population, 70.7% had their nasogastric tubes 
removed and 61.0% started oral fluids on the day of surgery. The first postoperative 
day 70.7% of the patients mobilized out of bed and 48.8% resumed normal diet. 
Patients from the ERAS group stayed in hospital for a significantly shorter 
time than those in the conventional care group: median 8 days (interquartile 
range (i.q.r.) 6-18.5) versus 12 days (i.q.r. 9-17.5) (P<0.005; Table 3).  
ERAS (n=41) Control (n=82) P
Median LOS (days) 1 8 (6-18.5) 12 (9-17.5) <0.005 3   
LAR 8 (6-12) 10 (8-14)  0.035 3 
APR 8 (7-22) 14.5 (10-24)  0.034 3 
Median total LOS (days) 1 9 (7-20.5) 13 (9-19)  0.040 3 
Readmissions 2 17.1 (7) 7.3 (6) 0.203 4  
Re-laparotomies 2 17.1 (7) 9.8 (8) 0.242 4
Mortality 2 2.4 (1) 1.2 (1) 1.000 5
1 Values are median (interquartile range)
2 Percentages (absolute number) 
3 Mann-Whitney U test
4 chi square test 
5 Fisher’s Exact test. 
LOS: postoperative length of stay. Total LOS: includes time in hospital during readmission.
ERAS versus conventional perioperative care in rectal surgery
Table 3. Length of stay, readmissions, re-laparotomies and mortality .
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Subgroup analysis revealed that patients undergoing LAR and APR both had 
a shorter length of stay. Although not significant, there was a trend towards 
more readmissions in the ERAS group. The total length of stay, however, was 
still shorter for ERAS patients: median 9 days (i.q.r. 7-20.5) versus 13 days 
(i.q.r. 9-19). The total number of complications did not differ in the control group 
compared to the ERAS group (68/82 vs. 31/41; P=0.334; Table 4). 
ERAS (n=41) Control (n=82) P
Surgical complications 22.0 (9) 31.7 (26) 0.258 2
  Wound hemorrhage 0 0 1.000 3
  Deep hemorrhage 0 1.2 (1) 1.000 3
  Anastomotic leak 4.9 (2) 3.7 (3) 1.000 3
  Wound infection 9.8 (4) 20.7 (17) 0.127 2
  Deep infection 9.8 (4) 6.1 (5) 0.479 3
  Burst abdomen 2.4 (1) 1.2 (1) 1.000 3
Medical complications 34.1 (14) 37.8 (31) 0.691 2
DVT/embolus 0 0 1.000 3
Chest infection 14.6 (6) 7.3 (6) 0.212 3
Cardiac failure 0 2.4 (2) 0.552 3
 Urinary infection 14.6 (6) 22.0 (18) 0.334 2
Septicemia 4.9 (2) 4.9 (4) 1.000 3
Pyrexia of unknown origin 0 2.4 (2) 0.552 3
Impaired renal function 7.3 (3) 2.4 (2) 0.332 3
Hypotension 4.9 (2) 6.1 (5) 1.000 3
Respiratory failure 2.4 (1) 2.4 (2) 1.000 3
Total number of complications 1 31 68 0.334
Patients with complication(s) 39.0 (16) 56.1 (46) 0.074
Data are percentages with absolute numbers in parentheses, unless indicated otherwise. 
1 Absolute number 
2 chi square test 
3 Fisher’s Exact test 
39.0% of the ERAS patients had complications, compared to 56.1% in the conventional 
care group (P=0.07). Subgroup analysis of surgical complications, medical 
complications or each type of complication separately, failed to reach significance. 
Seven ERAS patients (17.1%) had complications which required re-laparotomy, 
against eight in the control group (9.8%); P=0.242. Reasons for re-laparotomy 
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ERAS (n=41) Control (n=82) P
Mobilization 1 1 (1-1) 4 (2-5) <0.001 3 
Oral fluids 1 0 (0-1) 2 (1-3) <0.001 3
Solid food 1 1 (1-3) 5 (4-8) <0.001 3
Defecation 1 2 (1-4) 4 (3-6) <0.001 3
Nasogastric tube 2 0 (0-1) 3 (2-6.75) <0.001 3
IV fluids 2 4 (2-8.75) 6 (4.75-12) 0.002 3
Epidural analgesia 2 2 (2-2) 2 (1-2) 0.050 3
Opioids 2 3 (2-4) 3 (1-5) 0.774 3
NSAID’s 2 6 (3-8) 6.5 (2-12) 0.643 3
Paracetamol 2 7 (6-13.75) 10 (7.5-15) 0.006 3
in the ERAS group were perforated small intestine (1), anastomotic leakage (2), 
obstructive ileus (1), bowel necrosis (1), pelvic abscess (1) and burst abdomen (1). 
Control patients underwent re-laparotomy for anastomotic leakage (2), surgical site 
infection (1), burst abdomen (1), stoma necrosis (1), persistent ileus (1) and deep 
hemorrhage (1). In the ERAS group, one patient died on day 64 while hospitalized, 
due to multi organ failure and fecal peritonitis after a perforated small intestine. 
In the control group, one patient died on day 7 during admission, as a result of 
septicemia caused by generalized peritonitis after anastomotic leakage and 
re-laparotomy (P=1.000). Functional recovery was quicker in the ERAS group, as 
shown in Table 5.       
Expressed as median number of days (i.q.r.). 
1 First postoperative day it was introduced 
2 Postoperative day it was stopped. 
3cMann-Whitney U test 
Mobilization and bowel movement started more rapidly, and oral fluids and 
normal diet were introduced at an earlier time after surgery (P<0.001). In the 
study population nasogastric tubes were removed on day 0 (i.q.r. 0-1) compared 
to day 3 (i.q.r. 2-7) in the conventional care group (P<0.001). Intravenous fluid 
administration was stopped 2 days earlier in the ERAS group (P=0.002). 
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Table 5. Functional recovery.
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Discussion
The present study shows that ERAS perioperative care reduces length of hospital stay 
after low anterior resection and abdominoperineal resection. The use of epidural 
anesthesia, readmission rates, mortality and morbidity did not change significantly. 
This report is a cohort study with carefully case-matched controls undergoing 
rectal surgery, resulting in two highly comparable groups. In contrast to several 
other articles, we also included multimorbid and senile patients without an 
age limit and those who had undergone previous abdominal surgery, thereby 
giving a valid image of the value of ERAS in these complex patients. This study 
however, has its drawbacks. A historical control group may give less reliable 
information about the parameters used and underestimate postoperative 
morbidity. Second, by non-randomizing the patients both groups may differ 
with regard to patient characteristics, primary diagnosis, co-morbidity and 
treatment. Too minimize this bias we performed a case matched controlled 
study. Discharge policies were identical in both groups, further reducing bias. 
While data on ERAS patients were collected prospectively, information on 
the control group was gathered retrospectively. This has likely led to an 
underreporting of complications in the historical group and thereby could have 
diminished the reported difference in complications between groups. The same 
applies to the effect of neoadjuvant treatment, more frequently and intensely 
applied in today’s patients and rendering ERAS patients more prone to adverse 
events. Our data might therefore underestimate the beneficial effect of ERAS.
In an enhanced recovery protocol, patients undergoing rectal resection have shown 
to have longer hospital stays than those getting colonic surgery.(19) In this study, 
ERAS showed to reduce LOS from a median of 12 days to 8 days in rectal surgery 
(P<0.005). This is in agreement with others reporting on the effects of ERAS in 
rectal surgery.(16,20,21) Delaney et al.(22) achieved mean (standard deviation) 
LOS of 4.6 (1.7) and 3.8(0.8) days following complex colorectal surgery with and 
without co-morbidity respectively. Patients however were much younger (mean 
age 44.4 years) and mostly had their surgery for inflammatory bowel disease 
(62%), and only 22% for (recurrent) cancer. Patients studied by Schwenk et al. 
were comparable regarding age and all had rectal surgery, but with the major 
difference that 56% of procedures were performed laparoscopic.(20) Laparoscopic 
surgery can cause less postoperative pain and quicker recovery and could 
therefore be a promising addition to enhanced recovery protocols.(23,24)
Further trials are needed to make statements on possible beneficial effects
of ERAS and laparoscopy. Since hospital stays have decreased in many centers 
over the past 10 years even without institution of specific ERAS protocols 
(due to changes in payment, practice, and surgeon and patient expectations), 
evaluating the influence of such protocols on length of stay remains worthwhile. 
In this study, total LOS (including days after readmission) was significantly shorter 
in het ERAS program (P<0.05). This shows much resemblance to the study 
of Nygren et al.(16), who reported a significant shorter total LOS despite 
increased readmission rates (ERAS: 19%, traditional: 4%) after rectal surgery. 
Chapter 4
61
ERAS versus conventional perioperative care in rectal surgery
Early discharge is likely to cause an increased readmission rate. Though, we noticed a 
trend towards more readmissions (ERAS: 17.1% vs. conventional: 7.3%, P=0.203) 
there was no significant difference in readmission rates between ERAS and 
control groups, a finding that is in accordance with a recent meta-analysis.(17) 
Proper use of adequate discharge criteria should prevent high readmission rates
in fast-track surgical care.  
In our ERAS group, 39.0% had one or more complications compared to 56.1% of 
the control group (not significant). Our complication rates may appear higher 
than many published articles on fast-track surgery and our previously published 
data but, like Hendry et al. showed in a large study, rectal surgery carries a 
higher risk of postoperative morbidity than colonic surgery.(18,21) Varying 
methods of reporting complications and differences between studied populations 
make the comparison of complication rates between studies difficult.(17)
Compliance with the ERAS protocol was good. Postoperative variables are both 
markers of protocol compliance and markers of recovery. It is would be interesting 
to know which key element(s) of ERAS program is responsible for enhanced 
recovery. In this study, patients within ERAS mobilized faster, resumed normal 
diets sooner with quicker return of gastrointestinal function and duration of 
intravenous fluid administration was shorter (all highly significant). A reduction 
in morbidity was found in the ERAS patients, although this difference was not 
significant. Length of hospital stay was much shorter in ERAS. The use of epidural 
anesthesia was comparable within both populations. Therefore, the beneficial 
effect of the enhanced recovery program is more likely to be related to other 
factors than to epidural anesthesia. This is consistent with the findings of Zutshi 
et al.(25), who could not find an advantage of thoracic epidural anesthesia 
over patient controlled anesthesia after major gastrointestinal resection in a 
fast-track postoperative care plan. However, the population in this study 
involved patients undergoing segmental intestinal resection and does therefore 
not correlate with patients who had rectal surgery. Marret et al.(26) performed 
a meta-analysis on the effect of epidural anesthesia in colorectal surgery and 
could not find a significant reduction in hospital stay due to this key element.
In conclusion, this study shows that ERAS helps to reduce hospital stay after 
low anterior and abdominoperineal resections. As in colonic surgery, enhanced 
recovery programs should be considered as standard care for rectal surgery.
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Abstract
Background
The reasons why patients fail the ERAS program and its impact are not known.
Objective
The aim of the study was to analyze the clinical courses of patients that deviate 
from the ERAS track and to evaluate subsequent morbidity.
Patients
104 consecutive patients underwent an open colorectal resection, 22 
laparoscopic and 49 patients had rectal surgery according to the ERAS program.
Main outcome measures
All failures to reach one or more of the main protocol goals (epidural catheter 
use, early mobility and dietary intake), complications and hospital stay. 
Endpoints were analyzed separately for open and colonic and rectal surgery.
Results
Protocol compliance after colonic surgery was 73.4%. 53.8% of the patients failed 
on one or more goals. Solitary epidural failure occurred in 25% of the patients, 
mobility failure in 2% and 7.7% failed on dietary goals. Patients who failed epidural 
goals had a similar complication rate and hospital stay. In patients with impaired 
mobility hospital stay was prolonged (median 6 days vs. 8.5 days; P<0.001). Patients 
with problematic dietary intake had more Dindo 3-4 complications (7.9% vs. 
28.6%; P<0.05) and were hospitalized longer (median 5.5 days vs. 8 days; P<0.05). 
After laparoscopic colonic surgery, 78.8% of the goals could be reached. 
59.1% of the patients were able to meet ERAS goals. Solitary epidural 
failure occurred in 27.3% and 13.6% failed the dietary guidelines. Dindo 1-4 
complications were similar in both populations. Patients who were able to follow 
the program were hospitalized shorter (median 5 days vs. 7 days; P<0.05). 
Protocol compliance after rectal surgery was 69.4%. 40.8% patients succeeded the 
ERAS goals. 12.2% failed epidural anesthesia following protocol, 4% had impaired 
mobility and 18.4% did not resume normal diet as scheduled. Patients with epidural 
failure experienced more Dindo 3-4 complications (20% vs. 57.1%; P<0.05). For 
patients who failed the mobility goals, more Dindo 3-4 complication were found 
(18.4% vs. 72.7%; P<0.01) and hospital stay was prolonged (median 7 days vs. 22 
days; P<0.001). Similar complication rate and hospital stay was found between 
patients who could and could not fulfill dietary ERAS goals after rectal surgery.
Chapter 5
67
Limitations
This study analyzed not all elements of the ERAS program.
Conclusion
About 30% of the goals regarding epidural use, mobility and dietary intake are 
not reached in an ERAS program. Over half of the patients undergoing colonic and 
rectal resections do not meet one or more goals of the protocol. It is likely that 
the more severe complications interfere with protocol compliance, but other 
factors might contribute also.  
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Introduction
Enhanced Recovery After Surgery (ERAS) programs are associated with reduced 
hospital stay and a lower morbidity in patients undergoing colorectal resections 
when compared to traditional care.(1-7) The program aims to reduce the stress
response by providing adequate pain relief and fluid restriction, facilitating 
recovery of gastro-intestinal function and early mobilization.   
Still, a considerable proportions of patients does not reach these goals 
but protocol compliance has hardly been reported on.(5;8)  
The aim of the study was to analyze how patients come to have  clinical courses 
aberrant from the ERAS track and to evaluate the consequences in terms of 
complications and hospitalization.      
Materials and methods
Patients
One hundred seventy-five consecutive adult patients that underwent a 
colorectal resection and who had an ASA score < 4 were included in the study. 
104 patients had open colonic resection, 22 underwent laparoscopic colonic 
resection. Rectal resections were performed in 49 patients: 24 had a low 
anterior resection and 25 underwent abdominoperineal resection. In 4 patients 
with a low anterior resection, an end colostomy was constructed; the other had 
a diverting ileostomy. Of the patients operated for rectal carcinoma, 45.2% had 
preoperative radiotherapy 5x5 Gray, 50% received 25x2 Gray and 4.8% of the 
rectal carcinoma were not irradiated for several reasons. Patient characteristics, 
indication for surgery and performed procedures are listed in Table 1.  
ERAS protocol
The ERAS protocol was described previously and compliance to the protocol 
was controlled and monitored with a checklist.(3;4) Patients were informed 
at the outpatient clinic about the operative procedure and the perioperative 
care, especially pain management, early mobilization and enteral feeding. The 
day before operation, a phosphate enema was given to all patients undergoing 
a left sided colon or rectal resection. No other bowel preparation was given. 
Oral carbohydrate loading was started at least 8 hours before surgery and 
was stopped 2 hours before induction of anesthesia. All patients received 
antibiotic and thromboembolic prophylaxis according to the local protocol. 
Surgery was done under a combination of general and epidural anesthesia via a
thoracic epidural catheter. The same team of surgeons performed all procedures.
In open procedures, a transverse laparotomy was preferred. In patients with 
inflammatory bowel disease, undergoing rectal resections or the creation of a
stoma, a midline laparotomy was performed.  
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* Percentage, corrected for patients operated for malignancy. 
Nasogastric tubes and drains were avoided. Only in patients undergoing a rectal 
resection a presacral drain was placed during 24 hours postoperatively. All 
patients had a transurethral catheter until removal of the epidural catheter.
Perioperative analgesia was given with a continuous infusion containing 
Ropivacain 0.2% (2 mg/ ml) and Sufentanil 1 microgram/ml at a rate of 
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Open colonic 
surgery
(n= 104)
Laparoscopic 
colonic surgery 
(n=22)
Rectal surgery
(n=49)
Male: female 67:37 8:14 31:18
Age (mean/ SD) 54.9 (17.6) 45.5 (20.4) 63.5 (14.1)
Body Mass Index (mean/ SD) 25.6 (4.5) 23.6 (4.3) 25.3 (4.3)
Diabetes (%) 9.6 4.5 2.0
ASA (%)
ASA 1 25 23.6 26.5
ASA 2 57.7 77.3 46.9
ASA 3 17.3 9.1 26.5
Indication (%)
Malignancy 64.4 27.3 85.7
Inflammatory bowel disease 27.9 68.2 6.1
Diverticulitis 2.9 4.5 2.0
Other 4.8 - 6.1
Resection (%)
Ileocecal 16.3 36.4
Right hemicolon 31.7 4.5
Transverse colon 1.9 4.5
Left hemicolon 17.3 4.5
Sigmoid 13.5 13.6
Subtotal colon 19.2 36.4
Low anterior 51
Abdominoperineal 49
Stoma formation
Diverting ileostomy 38.8
End colostomy 59.2
Radiotherapy*
     None 4.8
     5x5 Gy 45.2
     25x2 Gy 50
Table 1. Demography, indication for surgery and performed procedures.
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6 ml/hour, via an epidural catheter (T 7-8). Pain was monitored with a visual 
analogue scale (VAS).  If the VAS score remained greater than 5 in patients having 
a proper level of pain blockade, an epidural bolus with 3-4 ml Lidocain 2% was 
given. In case of persisting pain, patients also received Ketamin intravenously 
via a continuous infusion. If epidural analgesia failed, the epidural catheter 
was removed and intravenous morfinomimetics were administered via an 
on-demand patient controlled infusion system. Oral analgesics (Naproxen 2 
dd 500 mg or Diclofenac 3 dd 50 mg) were started after starting oral feeding.
Postoperative fluid intake was restricted to 2 liters per day, with allowance 
of a positive fluid balance of 500 ml. Oral fluid intake was started on the day 
of surgery and a normal diet was started as soon as tolerated. Normal diet 
was defined as the eating of solid food in any desired quantity and without 
restrictions to the composition of the food or the way of preparation. All 
patients received Magnesium oxide 2 dd 500 mg as laxative. Mobilization was 
started on the day of surgery. Sitting at the edge of the bed was encouraged 
on the day of operation and patients were stimulated to walk the corridor of 
the ward on the first postoperative day. In case of impaired mobility, regaining 
the preoperative mobility level was attempted on the first postoperative day.
Discharge criteria were adequate pain relief (VAS score <5) on non-opioid 
oral analgesia, adequate oral food intake and return of preoperative 
mobility level. Bowel movement was not mandatory before discharge. 
Definition of ERAS failure
Adequate epidural analgesia, early mobilization and oral intake are the 
cornerstones of the ERAS protocol. Each inability of the patient to reach 
the goals as set in the protocol was considered as ERAS failure. These 
goals were: (1) stress and pain relief by epidural anesthesia; (2) timely 
mobilization as scheduled; (3) early intake of solid foods according to schedule. 
Epidural failure was defined as insufficient pain relief by epidural analgesia 
(VAS >4) necessitating an epidural bolus or the use of intravenous/ 
subcutaneous opioids or the removal of the epidural catheter earlier 
than on the second or the morning of the third postoperative day. 
Mobilization failure was defined as mobilization more than one day behind 
schedule. Resuming a normal diet more than one day behind schedule was
defined as a diet failure.  
Data extraction and analysis
The following data were recorded: sex, age, indication for surgery, type 
of operation, ASA grade, daily intravenous and oral fluid intake, daily fluid 
balance, removal of the epidural catheter, first day of mobilization, length of 
postoperative hospital stay, number of readmissions, complications and mortality. 
All failures to adhere to the enhanced recovery protocol were recorded. 
Epidural anesthesia, early mobility and feeding were decided to be the main items 
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in the enhanced recovery program. Data related to these items were gathered 
prospectively. As stated above, failure regarding these goals was clearly defined. 
Outcomes for colonic (open versus laparoscopic) and rectal surgery were analyzed 
separately, since these procedures are known to have a different hospital stay 
and complication rate. Delayed discharge and the incidence of complications 
were not considered as ERAS failure but used as an outcome measure instead. 
Complications were classified according to Dindo et al.(9) Postoperative 
ileus requiring total parenteral nutrition, pulmonary or urinary infection, 
urinary retention, delirium were considered as Dindo grade I-II.  Postoperative 
complications requiring surgical / radiological intervention or ICU admission 
were classified as Dindo grade III-IV (e.g. superficial and deep surgical site 
infection, bleeding, anastomotic leakage, iatrogenic injury, fascia dehiscence). 
Statistical analysis
Comparisons were made using the chi-square test for binary outcomes and the 
student’s t test was used for continuous outcomes. 
Results
Open colonic surgery
Median hospital stay was 6 days (range 3-110 days). The readmission rate was 
3/104 (2.9%). All patients readmitted within 30 days of discharge had experienced 
complications. The total number of ERAS goals that could have been fulfilled was 
312. The population under study successfully reached 229 goals (73.4%). Of the 
83 goals not reached, 40 regarded epidural anesthesia, 28 dietary and 15 mobility 
guidelines. 56 patients (53.8%) failed on one or more goals. Solitary epidural 
failure occurred in 25% of the patients, mobility failure in 2% and 7.7% failed 
on dietary goals only. 18.3% failed to reach two goals and 2.9% failed all three. 
The only demographic difference that could be identified between the ERAS 
success and failure population was a higher body mass index in the patients who 
could reach ERAS goals. The incidence of complications in the population who 
failed was 42.9%, which differs not significantly to the 25% complication rate 
of the patients who were able to meet ERAS goals. The number of Dindo 1-2 
complications was 8 (in 8 patients; 16.7%) in the success group and 16 (in 15 
patients; 26.8%) in the ERAS failures (not significant). For Dindo 3-4 complications, 
this amounted 7 (in 4 patients; 8.3%) and 20 (in 11 patients; 19.6%) respectively 
(not significant). The total number of complications was higher in patients who 
did not manage to reach ERAS goals (36 vs. 15; P<0.01). Patients able to fulfill 
ERAS goals were hospitalized shorter (median 5 days, range 3-35 vs. median 7, 
range 3-110; P<0.05). Readmission rate was similar (2.1% vs. 3.6%; not significant). 
Patients who failed epidural goals were compared with those who did not. There 
were no differences in Dindo complication rate and hospital stay. Patients who 
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failed to reach the mobility goals did not experience more complications, but 
hospital stay was prolonged (median 6 days, range 3-45 vs. median 8.5 days, range 
6-110); P<0.001). Patients with difficulties to reach dietary goals experienced 
more Dindo 3-4 complications (7.9% vs. 28.6%; P<0.05) and were hospitalized 
longer (median 5.5 days, range 3-110 vs. median 8 days, range 4-50; P<0.05).
Patients who failed the program experienced more blood loss and received more 
intravenous fluids intraoperatively than patients who succeeded to reach ERAS 
goals (mean 644 mL vs. mean 405 mL; P<0.05 and mean 2465 mL vs. 1925 mL; 
P<0.05, respectively). Patients who succeeded had less intravenous fluids on 
postoperative day 2 (mean 867 mL vs. mean 1333 mL; P<0.05) and drank more 
during the first two postoperative days (day 1: mean 1660 mL vs. mean 970 mL; 
P<0.001 and day 2: 1735 mL vs. 1344 mL; P< 0.05). Patients, succeeding the 
program and developing complications, retained fluid from postoperative day 3. 
Patients exceeding a daily total fluid intake of more than 2000 mL did not differ
between ERAS success and ERAS failure for 5 postoperative days. 
On postoperative day 2 and 5, significant more patients in the ERAS 
failure group had a fluid balance >+500 than the success group (day 
2: 51.8% vs. 20.8%; P>0.05 and day 5: 48.8% vs. 16.7%; P<0.05).
Irrespective of ERAS, increased blood loss and intraoperative fluid supply was 
associated with the occurrence of adverse outcome (mean 820 mL vs. mean 
376 mL; P<0.001 and mean 2705 vs. mean 1948 mL; P<0.01, respectively). 
Laparoscopic colonic surgery
Median hospital stay was 5 days (range 3-20). No patient had to be readmitted. 
Of the 66 goals set, 78.8% could be reached. This percentage is comparable to 
open colonic procedures (73.4%). Failures comprised 8 goals regarding epidural 
anesthesia, 1 mobility goal and 5 goals in resuming a normal diet. 13 out of 
22 patients (59.1%) were able to meet ERAS goals, compared to 9 (40.9%) 
who failed one or more goals. Solitary epidural failure occurred in 27.3% and 
13.6% failed the dietary guidelines. 4.5% failed on epidural and dietary goals 
and 4.5% failed all three. Compared to open colonic surgery, significant fewer 
patients failed on two goals after a laparoscopic procedure (18.3% vs. 4.5%; 
P<0.05). No demographic differences could be found between patients who 
did succeed the program and those who were not. Dindo 1-2 complications 
were similar in both populations (success: 1 vs. failure: 3; not significant), 
as were Dindo 3-4 complications (success: 1 vs. failure: 1; not significant). 
Patients who were able to follow the program were hospitalized shorter 
(median 5 days, range 4-7 vs. median 7 days, range 3-20 ; P<0.05). 
No differences could be found in blood loss, perioperative intravenous fluid 
supply, oral fluid intake and fluid balances for the first 5 postoperative days 
between patients who succeeded the program and ERAS failures. 
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Rectal surgery   
Median hospital stay was 8 days (range 3-76). There were 8 (16.3%) 
readmissions, which are higher than after colonic surgery (2.9%; P< 0.01). 
102 out of 147 goals were successfully reached (69.4%; not significantly different 
from open or laparoscopic colonic surgery). 14 epidural goals, 11 mobility goals 
and 20 dietary goals were not met. 12.2% had no epidural anesthesia following 
protocol, 4% had difficulties to reach mobility goals and 18.4% were not able to 
resume normal diet as scheduled. Compared to colonic surgery, the difference 
in epidural anesthesia failure was not significant, but more patients failed 
resuming a normal diet timely after rectal surgery (18.4% vs. 7.7%; P<0.05). 
Ten patients (20.4%) failed two goals and 2 (4.1%) failed all three. 20 patients 
succeeded the ERAS goals (40.8%), which is comparable to the 46.2% in colonic 
surgery. Demographic differences could not be found between patients able to 
follow the program and those who could not. In the success group, 9 patients 
developed 10 Dindo 1-2 and 3 Dindo 3-4 complications. In the failures, 20 
patients experienced 22 Dindo 1-2 and 18 Dindo 3-4 complications. The Dindo 
1-2 complication rate is comparable, but the Dindo 3-4 complications are more 
frequent in ERAS failures (P<0.01). Total complication rate is higher in ERAS failures 
(40 vs. 13; P<0.05), but the number of patients with complications is similar.
Patients who failed epidural anesthesia goals were compared to those who 
were not. The number of Dindo 1-2 complications and hospital stay did 
not differ, but failures experienced more Dindo 3-4 complications (20% vs. 
57.1%; P<0.05). For patients who failed the mobility goals, more Dindo 3-4 
complication were found (18.4% vs. 72.7%; P<0.01) and hospital stay was 
prolonged (median 7 days, range 3-32 vs. median  22 days, range 7-76; P<0.001). 
No significant differences in complication rate and hospital stay could be 
found between patients who could en could not fulfill dietary ERAS goals.
No differences could be identified in intraoperative blood loss and fluid supply 
between patients who were able to reach ERAS goals and those who could not, 
nor for patients with or without complications.  
Patients who successfully follow ERAS received less intravenous fluids on 
postoperative day 2 (mean 700 mL vs. mean 1322 mL; P<005), 3 (mean 392 mL 
vs. mean 1081 mL; P< 0.01) and day 4 (mean 559 mL  vs. mean 1211 mL; P<0.05) 
and drank larger volumes on day 2 (mean 1648 mL  vs. mean 1126 mL; P<0.05)
and 3 (mean 1585 mL vs. mean 1168 mL; P<0.05). There were no 
differences in the number of patients exceeding a daily total fluid intake of 
2000 mL or a more than +500 mL positive fluid balance between ERAS success 
and ERAS failures. 
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Discussion
About 30% of the goals regarding epidural use, mobility and dietary intake 
are not reached in an ERAS program. Over half of the patients undergoing 
colonic and rectal resections do not meet one or more goals of the protocol. 
The number of patients experiencing complications does not differ between 
the population able to fulfill ERAS goals and those who are not. However, 
complications may interfere with reaching goals. Total complication rate 
was higher in ERAS failure. Dindo 1-2 complications could not be associated 
with ERAS failure, but Dindo 3-4 complications were found to be related to 
decreased protocol compliance. Patients who manage to reach protocol goals 
are hospitalized shorter after (open and laparoscopic) colonic and rectal surgery.
In most articles on fast track surgery protocol compliance is hardly or not reported 
on.(5;8) In our institution, a written protocol is available, fulfilling all major ERAS 
criteria as formulated by Fearon et al. in their consensus review.(1) Moreover, doctors 
and nurses were frequently instructed and a bedside checklist was used in every 
single patient. Compliance was good for most ERAS denominators, but frequently 
pain management, postoperative mobilization and restoration of oral intake failed. 
Epidural anaesthesia goals
A considerable proportion of patients did not receive epidural anaesthesia as planned. 
Although exact reasons for failure could not be retrieved, this questions insertion 
technique, fixation method, preoperative testing and perioperative monitoring. 
There is no evidence as to the choice of the optimal anaesthetic method based on 
morbidity or recovery data from colorectal procedures. Several studies state that 
epidural anaesthesia provides superior pain relief as measured by postoperative pain 
scores. Patient controlled anaesthesia is thought to impair gut motility. Epidural 
anaesthesia may avoid systemic opioid use and is advocated to decrease the rate 
of postoperative ileus and pneumonia by some authors. There is clear evidence 
that a thoracic epidural can block many of the components of the stress response 
to injury and has been proven to reduce the duration of postoperative ileus.
For colonic surgery, postoperative morbidity and hospital stay were similar 
in patients who had adequate epidural anaesthesia compared to patients with 
inadequate thoracic epidural anesthesia or patient-controlled anaesthesia.(10-13) 
This is in accordance with Zutshi et al.(14), who studied the use of preemptive 
epidural analgesia after laparotomy and intestinal resection in a fast track 
postoperative care plan found no advantage of thoracic epidural placement over 
patient controlled analgesia regarding hospital stay, pain scores, quality of life 
and complications. In a meta-analysis, Marret et al.(15) also concluded that 
epidural use did not shorten hospital stay, even after introduction of enhanced 
recovery programs. Levy et al.(16) questioned the use of epidural anesthesia in 
laparoscopic colorectal surgery and spinal or patient controlled anesthesia are 
advocated. Evans et al.(17) states that the use of transversus abdominis plain 
blocks is safe and effective in ERAS. Wongyingsinn et al.(18) found similar effects 
on bowel function of perioperative infusion of lidocain in patients undergoing 
laparoscopic colorectal resection in an enhanced recovery program compared 
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with thoracic epidural anesthesia. This finding is in accordance with Herroeder 
et al.(19) who found an accelerated return of bowel function and a reduction 
in hospital stay after colorectal surgery compared to placebo in patients 
not able or unwilling to have epidural anesthesia. Although epidural failure in 
laparoscopic colonic surgery was as high as in open surgery in this study, the 
limited number of performed laparoscopic procedures does not allow further 
conclusions on the efficacy of epidural anesthesia in laparoscopic surgery.
In this study, epidural failure in rectal surgery was less frequent than in colonic 
surgery, but was associated with more Dindo 3-4 complications and prolonged 
hospital stay. The lower incidence might be explained by the fact that patients with 
rectal surgery often receive simultaneous patients controlled anesthesia for pelvic 
pain not adequately blocked by thoracic epidural anesthesia. Due to the systemic 
opioids, insufficient epidural pain blockade might be less prominent. The relationship 
with an increased complication rate is not clear, but one of the explanations 
could be the fluid shifts accompanied with epidural anesthesia that might cause 
hypotension and subsequent intravenous fluid loading. The efficacy of epidural 
anesthesia specified for rectal surgery only is underreported in the literature. 
Mobility goals
Early mobilization after surgery is important to prevent complications by 
decreasing insulin resistance, muscle wasting, pulmonary dysfunction and 
improving tissue oxygenation.(20-22) Possible factors delaying mobilization are 
pain, fear, preexistent diseases and the inability of the nursing staff to help the 
patient. In colonic surgery, impaired mobility was not found to be associated 
with a higher complication rate but delayed discharge from the hospital. 
For rectal surgery, it was more likely that an increased incidence of Dindo 3-4 
complications was responsible for impaired mobility and prolonged hospital stay.
Dietary goals
Gastro-intestinal function is impaired after laparotomy. Several measures in the 
ERAS protocol are aimed at improving gastro-intestinal transit, amongst which is 
oral feeding. After colonic surgery, the patients not able to fulfill the dietary goals 
had more often Dindo 3-4 complications and were hospitalized longer. It can be 
questioned what the effect of resuming a diet the first and second postoperative 
day is on the return of gastrointestinal function and adverse outcome. Patients, 
succeeding the program and developing complications, retained fluid from 
postoperative day 3. It is known that the inability to tolerate oral intake 
in the early postoperative phase is associated with fluid overload.(23-26) 
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Fluid
Fluid restriction appears to be an important part of the ERAS protocol. The largest 
intravenous fluid volumes were administered during surgery, part of which can 
be explained by the 500 ml bolus that was given routinely to all patients with 
an epidural catheter to prevent hypotension. Regional anesthesia to the upper 
thoracic dermatomes is associated with reduction in preload and cardiac sympathic 
drive, resulting in reduced cardiac output and hypotension. Holte et al.(27) have 
questioned the necessity of a fluid bolus since low levels of epidural anesthesia 
(T8) only result in minimal circulatory changes, as the upper part of the body 
is sufficient to offset the dilatation in the lower extremities. Probably it is wise 
to abandon a routine intravenous fluid bolus in patients with epidural anesthesia 
to prevent excessive fluid intake. Patients who failed ERAS suffered significant 
more blood loss during colonic surgery than patients who succeeded the ERAS 
program. Subsequently, intraoperative fluid volumes supplied were larger in ERAS 
failures. Despite increasing awareness on fluid supply, the most common cause 
for postoperative overloading was insufficient adaptation of the intravenous fluid 
management to changes in oral intake and diuresis during the day. Fluid overloading 
during and early after surgery might induce complications that typically appear 
later in the postoperative course. It is likely that a positive fluid balance on the 
third postoperative day onwards, is rather a consequence of complications (ileus, 
surgical site infections) than a causal factor. In this study, fluid overloading was 
similar between patients who succeeded and failed ERAS, but oral intake was 
higher in patients who succeeded. This indicates that patients who failed received 
more intravenous fluid volumes. The impact of intravenous saline on postoperative 
complications might differ from oral fluids taken and needs further study. 
However, until now insufficient data are available to give evidence-based guidelines 
for perioperative fluid management.(20;21;28) Intraoperative Doppler-guided 
titration of fluid is a promising technique to determine fluid requirements 
during colorectal surgery but heterogeneity of published trails, improvements in 
perioperative care and surgical technique limit this technique to be 
used as a routine.(29;30)      
This study indicates that about 30% of the goals regarding epidural use, mobility 
and dietary intake are not reached in an ERAS program. Over half of the patients 
undergoing colonic and rectal resections do not meet one or more goals of the 
protocol. It is likely that the more severe complications interfere with protocol 
compliance, but other factors might contribute also.  The influence of epidural 
analgesia is remote in colonic surgery, but its role in rectal surgery is less clear. 
Impaired early mobility causes prolonged hospital stay in colonic surgery and is 
more frequent after complicated rectal surgery. The ability to fulfill ERAS dietary 
guidelines is diminished due to complications after colonic surgery. Problematic 
dietary intake has a less prominent relationship with complications and hospital 
stay after rectal surgery. Intravenous fluid overloading is associated with ERAS 
failure and the occurrence of complications and should receive attention.
Further research is necessary to point out most beneficial aspects 
of enhanced recovery programs.    
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Chapter 6
Abstract
Background
Esophageal Doppler monitoring is a minimally invasive technique to determine 
cardiovascular status and the response to fluid loading. The aim of this meta-
analysis was to obtain evidence regarding the effect of intraoperative Doppler-
guided fluid titration on the recovery after colorectal surgery.
Methods
Studies were selected for inclusion if they were randomized clinical trials 
including adult patients who underwent colorectal surgery. The intervention 
was intraoperative Doppler-guided fluid titration, compared with standard  
fluid management. Methodology of all reports was assessed according to the 
Cochrane Handbook. Primary outcome measures were the Doppler variables 
stroke volume and corrected flow time. Secondary outcome measures were  
hospital stay, complications and time to tolerance of oral solids.  
 
Results
In patients with intraoperative Doppler-guided fluid administration, stroke 
volume was increased with 14.6 ml (Weighted mean difference, 95% CI = 9.0 to 
20.1) and corrected flow time was prolonged with 0,025 sec (Weighted mean 
difference, 95% CI = 0.014 to 0.036) compared to the control group. The difference 
in hospital stay was not significant (-1.1 days; Weighted mean difference, 
95% CI = -2.3 to 0.1).  
In the experimental group, total complication rate was reduced 
by 15.8% (Weighted mean difference, 95% CI = -0.29 to -0.02)
and patients were able to tolerate oral solids 1.4 days earlier (Weighted mean 
difference, 95% CI = -2.1 to -0.8).      
Conclusion
Intraoperative Doppler-guided titration of fluid reduces morbidity and the 
time to tolerate oral solids after colorectal surgery. This conclusion must be 
interpreted with care because the studies are heterogeneous and results may be 
confounded by improvements in surgical technique and perioperative care. 
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Introduction
Fast track surgery and enhanced recovery programs are rapidly developing 
and are becoming standard of care. (1-4) One of the key elements of these 
programs is peri-operative fluid management. Especially, patients who 
undergo colorectal surgery are threatened by hypovolemia due to fasting, 
bowel preparation, epidural anaesthesia, blood loss and insensible fluid loss. 
So far, no widely accepted recommendations are available for the optimal 
perioperative fluid regimen. A normovolemic state is a prerequisite for optimal 
cardiac and pulmonary function thus guaranteeing adequate tissue oxygenation 
and wound healing. Moreover, gastro-intestinal motility, renal function and 
coagulation may all benefit from optimal perioperative fluid administration.(5-10) 
To optimize cardiovascular function, several invasive methods were developed 
to assess the circulatory status. The Swan-Ganz catheter is the gold standard 
in evaluating fluid responsiveness and cardiac function. However, this technique 
is expensive and has a considerable complication rate not outweighing
its benefits.(11-13) Esophageal Doppler monitoring is a minimally invasive 
method to determine cardiovascular status and response to fluid loading. 
Esophageal Doppler measures blood flow in the descending aorta by a Doppler 
probe in the esophagus. It generates a flow velocity waveform. The most important 
parameters determined are: stroke distance, stroke volume and flow time. 
Stroke distance is the distance a column of blood moves in the descending aorta 
after each left ventricular contraction. Stroke volume, one of the most essential 
parameters, is the product of stroke distance and aortic cross-sectional area. 
The flow time indicates the time of antegrade blood flow in the descending aorta 
with each ventricular stroke. This flow time needs to be corrected for heart rate: 
‘the corrected flow time (cFT)’, which normally varies between 0.33 and 0.36
seconds.(14)   
The splanchnic perfusion is of utmost importance for patients undergoing 
colorectal surgery. Hypovolemia is accompanied with a redistribution of 
blood at the expense of the splanchnic circulation. Redistribution may remain 
unnoticed because pulse rate and systemic blood pressure may remain normal 
whereas tissue oxygenation of the viscera, especially the gut mucosa, 
is at risk.(15;16) 
Mythen and Webb(17) found that optimalisation of the cardiac output with the
help of Doppler guided fluid management decreased gut mucosal hypoperfusion
in coronary artery bypass surgery. An accumulating number of clinical 
trials report on the value of hemodynamic monitoring by esophageal 
Doppler in patients undergoing colorectal surgery.  The aim of this meta-
analysis was to analyze studies concerning the effect of intraoperative 
Doppler-guided fluid titration on the recovery after colorectal surgery. 
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Methods
Study selection
The PubMed and Embase databases as well as the Cochrane Central Register 
of Clinical Trials were searched without limits in order to identify randomized 
clinical trials which studied the value of intraoperative esophageal Doppler-
guided fluid management compared to standard fluid administration 
during anesthesia in adult patients undergoing colorectal surgery. Relevant 
studies were initially identified by title, then by abstract and finally by 
full text. References of included articles were searched for further trials.
Assessment of study quality
Only prospective randomized clinical trials, comparing intraoperative Doppler-
guided fluid titration and standard fluid management during colorectal surgery 
were included in the meta-analysis. Studies had to meet the quality criteria of the 
Cochrane Collaboration. The quality of each publication was assessed using the 
Cochrane Handbook as reported by Parker et al.(18) This is a ten-point instrument 
indicating methodological quality of randomized clinical trials. Each included 
study can obtain a maximum score of 12 points. Concealment of allocation is the 
most dominant criterion (maximum of 3 points). All other criteria are graded 0 or 1. 
Outcome measures 
Primary outcome measures were the Doppler variables stroke volume and 
corrected flow time at baseline and at the end of surgery. Secondary measures 
were complication rate, hospital stay and the time to tolerance of oral solids. 
Statistics and analysis
Data on the Doppler variables, complication rate, hospital stay and time to 
tolerate oral solids were pooled. Bias assessment plots were constructed for each 
effect size. Heterogeneity was assessed by the Cohran Q test for non-combinability 
for studies. If inconsistency was lower than 20% fixed effects were used 
according to Mulrow Oxman. DerSimonian-laird random effects were calculated 
if inconsistency was more than 20%. The weighted mean difference (WMD) and 
the 95%-confidence interval were extracted for stroke volume, corrected flow 
time, complication rate, hospital stay and time to tolerance of oral solids.
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Results
The search yielded 193 PubMed and 127 Embase hits. Eighty articles were 
found in the Cochrane Central Register of Controlled Trials. After screening, 
full-text articles were retrieved for assessment of eligibility. A further 63 
studies were excluded, which left 6 studies to be included in the meta-analysis. 
An algorithm of the search is shown in Table 1. 
Table 1. Search algorithm.
All studies achieved more than 9 points on methodologic assessment according 
to the Cochrane Handbook (Table 2). 
Stroke volume and corrected flow time were reported for both the 
intervention group as well as the control group in most studies. 
Stroke volume was mentioned in five studies, including 578 patients. Pooled 
stroke volume at the start of the surgical procedure was similar in the Doppler 
and the control group: mean 76.7 ml (SD 7.5) vs. 76.0 ml (SD 6.8); P=0.87. Pooled 
stroke volume did not differ either at the end of surgery (Doppler: mean 92.5 ml 
(SD 14.1) vs. Control: mean 77.5 (SD 11.5); P=0.10. Weighted mean difference 
in stroke volume at baseline did not differ significantly between the Doppler 
and the control group: -0.24 ml (95% CI = -4.13 to 3.66). At the end of surgery, 
weighted mean difference stroke volume was significantly increased by 14.0 
ml (95% CI = 10.1 to 18.0) in the Doppler group compared to the control group.
The corrected flow time was reported in four studies, resulting in a pooled 
population of 444 patients. At the start of surgery, cFT was similar in both groups 
(Doppler: mean 0.363 sec (SD 0,017) vs. Control: mean 0.361 sec (SD 0.014); P=0.86). 
Intraoperative Doppler-guided fluid management 
PubMed
193
174
19
3
PubMed
127
98
29
3
Cochrane Central Register 
of Controlled Trials
80
65
15
5
Hits
Excluded
Analysed
RCT for 
meta-analysis
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Gan Noblett Wakeling Conway Senagore Challand
Concealment of allocation 3 3 3 3 2 2
Inclusion and exclusion criteria 1 1 1 1 1 1
Comparability of groups at 
baseline 1 1 1 1 1 1
Treatment protocol 1 1 1 1 1 1
Were the care programs 
identical, other than trial 
interventions?
1 1 1 1 1 1
Were outcome measures 
defined clearly? 1 1 1 1 1 1
Were outcome assessors blind 
to treatment group? 1 1 0 0 1 1
Timing of outcome measures 0 0 0 0 1 1
Intention to treat analysis 1 1 1 1 1 1
Loss to follow up 1 1 1 1 1 0
Total (max. 12) 11 11 10 10 11 10
At the end of the procedure, however, corrected flow time was longer in 
patients with Doppler titrated fluid administration (mean 0.390 sec (SD 0.007) 
vs. mean 0.361 sec (SD 0.002); P=0.002). Weighted mean difference in baseline 
corrected flow time was similar in both populations (0.002 sec; 95% CI = -0.006 
to 0.01). At the end of surgery, flow time was significantly increased by 0.028 
sec (95% CI = 0.020 to 0.035) in the Doppler group. Pooled differences in 
effect size were calculated for both Doppler variables between the baseline 
values and those at the end of surgery. This is shown in Figure 1 and 2.
Figure 1. Pooled weighted mean difference of stroke volume (ml).
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Table 2. Assessment of study quality according to Parker (29).
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pooled weighted mean difference = 14.56524
(95% CI = 8.989076 to 20.141404)
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Effect size meta-analysis plot [fixed effects]
All six studies, including 642 patients, reported on total complication rate. 
Doppler titrated fluid administration reduced total complication rate by 15.8% 
(pooled random effect size, 95% CI = 2.1 – 29.4%) compared to controls (Figure 3). 
Only three studies (including 298 patients) specified complications. 
Differences between specific complications could not be objectified. 
Regarding complication rate, heterogeneity between studies was considerable
(Cohran Q test: inconsistency 67.8%). Hospital stay was reported by all studies 
and did not differ between patients treated with esophageal Doppler and those
who were not (weighted mean difference: -1.1 day; 95% CI -2.3 to 0.1; Figure 4). 
Intraoperative Doppler-guided fluid management 
Figure 2. Pooled weighted mean difference of stroke volume (ml).
Figure 3. Pooled weighted mean difference in total complication rate.
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In the assessment of hospital stay, high inconsistency between 
studies was found (Cohran Q test: 81.8%).    
In the evaluation of the time to tolerate solid food after surgery between 
Doppler treated patients and conventional treated patients, only the 
data of Gan and Wakeling (including 234 patients) allowed comparison. 
Patients in the Doppler population were able to tolerate oral solids 1.4 
days earlier than control patients (95% CI = 0.8 -2.1 days; Figure 5). 
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Figure 4. Pooled weighted mean difference of hospital stay (days).
Figure 5. Pooled weighted mean difference in time to tolerate oral solids (days).
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Discussion
The use of esophageal Doppler seems to have moderate advantages to optimize 
fluid management during surgery. It increases stroke volume and prolongs 
corrected flow time. Moreover, it reduces total complication rate and the time 
to tolerate oral food intake. However, these findings have to be interpreted with 
caution. Heterogeneity between published randomized trials published so far, is 
considerable.  Since all trials under study are found to have reasonable methodology, 
inferior study quality is not likely to be responsible for this heterogeneity. 
Another major limitation of selected trials is the use of poorly defined outcome 
measures. Although all studies report that hospital stay is predefined, the 
criteria for discharge are not mentioned. Some studies use hospital stay, other 
report only time to surgical fitness for discharge. Complications are not defined, 
grouped by severity or organ system. In only one study complications were 
adequately reported using the Dindo classification.(19) This limits pooling of 
data and threatens conclusions on the value of esophageal Doppler monitoring. 
Furthermore, duration of follow up was short, cost-effectiveness analysis 
was not performed and complications related to the use of Doppler were
not mentioned in any study. Stroke volume and corrected flow time, which are 
the main outcome measures of Doppler guided intervention, were significantly
higher at the end of surgery, when Doppler guided intervention was utilized. 
Bundgaard-Nielsen et al. (20) questioned the use of corrected flow time as 
a marker of preload in fluid algorithms because it is likely to be
affected by several other factors. In fluid challenges, cFT values may increase
not as pronounced as the stroke volume.  
Although stroke volume and corrected flow time are frequently used as the 
main parameters in esophageal Doppler monitoring, it is important to realize 
that the relationship with gut perfusion and restoration of gastrointestinal 
function after colorectal surgery is not clear. One of the main ideas of 
non-invasive cardiac output esophageal Doppler monitoring is that fluid 
management can be individualised to the Frank-Starling curve to safely 
deliver intravenous fluids to optimise stroke volume. The main advantage 
of measuring flow in a major central vessel is that measurements are not 
affected by peripheral arterial compliance. So, esophageal Doppler is likely 
to reflect intravascular volume more accurate than clinical parameters (e.g. 
pulse rate and blood pressure). Mythen and Webb(17) found that optimisation 
of cardiac output with colloids during cardiac surgery, guided by esophageal 
Doppler, reduced gut mucosal hypoperfusion as measured with gastric 
intramucosal pH.  This resulted in a shorter intensive care and hospital stay. 
Whether Doppler guided fluid management also improves perfusion of the 
splanchnic circulation and the gut mucosa needs to be determined in future 
studies. The finding that the incidence of complications was reduced in the 
Doppler intervention group should be interpreted with caution. The definition 
of complications and the criteria for discharge were unclear and may not be 
uniform as mentioned before. Secondary outcome measures such as hospital stay 
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and complication rate are more likely to be influenced by other factors than by 
the use of intraoperative esophageal Doppler-guided fluid administration. 
It is likely that trials to determine the effect of Doppler guided fluid 
titration are affected by the changes in perioperative care and surgical 
technique. Most trials under study randomly used bowel lavage and epidural 
anaesthesia. Therefore further research on Doppler guided fluid titration 
integrated in Enhanced Recovery After Surgery programs are needed. 
Fluid therapy in colorectal surgery is widely discussed in the literature. Only three 
out of six studies reported the type and volume of the infused fluids. It is likely 
that the type of fluid is a relevant variable. Senagore et al.(21) state that larger 
volumes of crystalloid solutions are necessary to reach desired stroke volumes 
compared to colloids. Lang et al.(22) report an improved tissue oxygen tension 
in favour of colloids compared to crystalloids in patients undergoing major 
abdominal surgery. It is remarkable that the administered amount of fluid 
was larger in the Doppler group than in the controls in this meta-analysis. 
This is not consistent with recent comparative reports on different fluid 
regimen in colorectal surgery in which most authors report a more favourable 
outcome and better functional recovery after restricted or goal-directed fluid 
therapy than in patients treated with standard fluids supply. Furthermore, 
Doppler only assessed intraoperative fluid management but postoperative 
intravenous fluid supply might play an important role as well.(8;23-28)
It is the final conclusion of this meta-analysis that the found statistical 
differences have to be interpreted with caution. Trial heterogeneity 
and confounding factors limit conclusions on the value of intraoperative 
esophageal Doppler monitoring in colorectal surgery. An important limitation 
in the pooling of data is the use of poorly defined outcome measures. 
It is to be questioned if used hemodynamic variables are indicative for 
optimal gut perfusion and restoration of gastrointestinal function. Further 
research on Doppler monitoring and alternative techniques to properly 
assess cardiovascular status, end-organ perfusion and the impact on surgical 
outcome in a standardized enhanced recovery program is necessary. 
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Hybrid F-18-fluorodeoxyglucose positron 
emission tomography- computer 
tomography of colonic anastomosis: a 
possibility to detect anastomotic leakage?
A pilot study
96
Abstract
Background
F-18-fluorodeoxyglucose positron emission tomography (FDG-PET) is a known 
method to diagnose inflammatory processes and thus may be a promising 
imaging technique to detect anastomotic bowel leak. The aim of this 
study was to assess postoperative FDG uptake in colorectal anastomosis 
in patients without suspicion of active infection or anastomotic leakage.
Methods
Design of a prospective observational pilot study in order to assess 
normal FDG uptake in the patent anastomosis after colorectal surgery. 
Patients that underwent colorectal surgery with primary anastomosis 
received FDG-PET of the abdomen, 2-6 days postoperatively. 
Results
Thirty-five patients met the inclusion criteria. Three patients were not scanned 
for various reasons. Of the remaining 32 patients, one demonstrated an increased 
uptake of FDG at the site of the anastomosis. In the other 31 patients FDG uptake 
was negligible (n=17) or scored as physiological (n=14). None of the scanned patients 
developed a clinical relevant anastomotic leakage within the first 30 days after 
surgery. 
Conclusion
The results of the present study show that FDG uptake in colorectal anastomosis 
remains low within the first 6 days after surgery in patients without anastomotic 
leakage. Therefore, FDG-PET might be useful to investigate further as a 
tool to detect anastomotic leakage in an early stage postoperative phase.
 
Chapter 7
97
Introduction
Anastomotic leakage remains a serious adverse event after 
colorectal surgery. Its reported incidence varies from 1-25%. This 
wide range is mainly caused by the lack of a uniform definition.(1;2) 
Diagnosing leaks relies on the clinical and radiographic findings. Early 
diagnosis and prompt treatment are essential since delay is associated 
with increased mortality and morbidity.(3;4) Den Dulk et al.(5) developed 
a leakage-score based on clinical parameters associated with anastomotic 
leakage. The leakage-score was implemented in a standardized postoperative 
surveillance and scoring led to a reduction in delay in diagnosis and mortality.
Radiological diagnosis by means of e.g. contrast radiography or computer 
tomography are often advised when a leakage is suspected in a patient. 
However, sensitivity of both contrast radiography and computer tomography 
for diagnosing anastomotic dehiscence are rather low, being 65% and 
54% respectively. Interobserver variability may be as high as 10%.(6;7) 
Meller et al.(8) studied the use of F-18-fluorodeoxyglucose positron emission 
tomography (FDG-PET) in 18 patients with postoperative fever. Sensitivity 
for detection of infectious and oncological foci was 100%. However, specificity 
was low as a result of false positive scans due to increased FDG uptake at 
the surgical wounds. Since leakage of bowel contents elicits at least a local 
inflammatory response, F-18-fluorodeoxyglucose positron emission tomography 
(FDG-PET) may be a promising imaging technique to improve the detection of 
anastomotic bowel leak, at an early stage when granulocytes and macrophages 
migrate to the inflammatory process. A first condition for such an application 
would be that the signal remains low during undisturbed healing.(9-11) 
Since negligible uptake of FDG at the site of the healing anastomosis is a prerequisite 
for early and accurate diagnosis of anastomotic dehiscence, we performed a 
prospective study to assess postoperative FDG uptake in colonic and colorectal 
anastomosis in patients without evidence of active infection or anastomotic leakage.
Methods
Patients who underwent a colorectal resection with primary anastomosis and gave 
informed consent were included in the study. The institutional review board of the 
Radboud University Nijmegen Medical Centre, the Netherlands, approved the study. 
Exclusion criteria were: suspicion of or proven infection, pregnancy, 
preoperative neutropenia, known HIV infection, known hypogammaglobulinaemia 
(IgG <50%), the use of prednisolone 10mg per day for the duration of at 
least 2 weeks in the three months prior to surgery, known inflammatory 
bowel disease, metastatic disease and uncontrolled diabetes (glucose 
level > 10 mmol/L or the use of insulin within 6 h prior to FDG-PET). 
Hybrid F-18-fluorodeoxyglucose positron emission tomography
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F-18-fluorodeoxyglucose positron emission tomography
All included patients underwent FDG-PET between two and six days after surgery. 
Patients fasted for at least 6 h before injection of FDG. Intake of non-caloric 
beverages was permitted. Intravenously administered fluids, if still necessary, 
contained no glucose. Hybrid PET/CT scans of the abdomen were acquired using 
a Biograph Duo (Siemens Medical Solutions USA, Inc.) containing a 2-slice CT 
scanner. A low-dose CT scan for localization and attenuation-correction purposes 
was acquired in the caudocranial direction from the thighs up to the diaphragm. 
Scanning parameters included 40 mA•s (50 mA•s for patient weight >100 kg and 60 
mA•s for >120 kg), 130 kV, 5-mm slice collimation, 0.8-s rotation time, and pitch of 
1.5, reconstructed to 3-mm slices for smooth coronal representation. CT scans were 
acquired during timed unforced expiration breath-hold. No intravenous contrast 
was applied. For PET, a 3-dimensional (3D) emission scan of the abdomen was 
acquired during free breathing, 60 min after intravenous injection of 13,8 [MBq] 
• patient weight [kg] / (min/bed position), which is approximately 250 MBq FDG 
(Mallinckrodt Medical, Petten, The Netherlands) and 10–15 mg furosemide. (12) The 
acquisition time per bed position was 4 min for emission only. Uncorrected emission 
images as well as images with CT-based attenuation correction were reconstructed, 
both using 2 iterations, 8 subsets (for visual interpretation) or 4 iterations, 16 
subsets (for quantitative interpretation), and a 5-mm 3D Gaussian filter.(12)
Image interpretation
Two experienced nuclear medicine physicians blinded to the postoperative course 
and results of other diagnostic tests interpreted all FDG-scans independently. 
The degree of FDG uptake at the site of the anastomosis was scored as absent 
or negligible (0), normal physiological bowel uptake (1) and pathologically 
increased FDG uptake (2). Disagreements were resolved by consensus.
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Results
Eighteen males and seventeen females, mean age 66.3 years (range 43- 85 years), 
were included in the study. Three patients were classified as ASA-I (American 
Society of Anesthesiologists), 21 ASA-II and 11 patients were categorized ASA-III. 
The indication for surgery was (pre-) malignancy (n=28), diverticulitis (n=2) and 
restoration of bowel continuity (n=5). Procedures performed included ileocecal 
resection (n=1), right hemicolectomy (n=15), left hemicolectomy (n=4), resection 
of the sigmoid (n=2), (low) anterior resection (n=8) and restoration of continuity 
(n=5; of which 2 ileorectal anastomosis). Median hospital stay was 6.5 days 
(range 3-34). The location was the anastomosis was in the right upper abdomen 
in 16 patients, in the left lower quadrant in 6 and 10 were located in the pelvis 
region. FDG-PET was performed after a median of 4 days (range 2-6)
after the construction of the anastomosis. FDG-PET could not be performed
in the early postoperative phase in 3 out of 35 included patients.
In two patients the intravenous infusion of glucose was  erroneously not  
discontinued. One PET could not be performed since the patient was too 
ill. No complication was observed during the follow-up of this patient. 
Seventeen scans were given a score 0, fourteen a score 1. Figure 1 shows an example 
of a patient after right hemicolectomy with normal FDG uptake. In only 1 out of 
35 scans, there was a disagreement between score 0 and score 1. After consensus, 
it was decided that score 1 was most appropriate. So, interobserver
variability was below 3%. 
One of the scans showed abnormal FDG uptake at the site of the anastomosis 
(score 2; Figure 2). The involved patient was an eighty-year-old woman who was 
treated for a symptomatic colonic stenosis, highly suspicious for malignancy. 
She underwent a left hemicolectomy and resection of the proximal jejunum. 
The postoperative course was prolonged due to ileus, for which 
she required parenteral nutrition.     
She went home 16 days after surgery with a normal gastrointestinal function. 
Pathology examination revealed Crohn’s disease, without disease activity 
in the resection margins.       
The median time interval between surgery and FDG-PET acquisition was 4 
days in both the PET-score 0 and the PET-score 1 group. Overall morbidity 
in both groups did not differ either (PET-score 0: 9/17 vs. PET-score 
1: 8/14; not significant, Table 1). Three patients underwent extensive 
adhesiolysis: two patients had PET-score 0 and one patient had PET-score 1.
Hybrid F-18-fluorodeoxyglucose positron emission tomography
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Figure 1. The arrow indicates normal FDG uptake after right hemicolectomy.
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Hybrid F-18-fluorodeoxyglucose positron emission tomography
Figure 2. The arrow indicates normal FDG uptake after left hemicolectomy.
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PET score 0: absent/ negligible FGD-uptake at the location of the anastomosis 
PET score 1: physiological uptake at the location of the anastomosis
PET score 2: pathological increased FDG-uptake at the location of the anastomosis
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Complication PET score 0
N=17
PET score 1
N=14
PET score 2
N=1
Total
N=32
Ileus 2 1 3
Gastro paresis 2 2
Superficial surgical site 
infection 2 2
Febris e.c.i. 2 2
Phlebitis 1 1
Atrial fibrillation 1 2 3
Pneumonia 2 2
Urinary tract infection 1 1
Delirium 2 3
Table 1. Complications after surgery (absolute numbers).
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Discussion
To the best of our knowledge, there are no reports on FDG-PET 
scanning of bowel anastomoses after colorectal surgery. The results of 
the present study show that FDG uptake in colorectal anastomosis is 
absent or physiological, in the first 6 days after surgery.  
Early diagnosis of anastomotic leakage is considered important for timely 
initiation of treatment. It was hypothesized that FDG-PET scanning might 
be helpful to diagnose anastomotic dehiscence at an early stage since uptake 
of FDG will probably be increased due to inflammation by leakage of bowel 
contents. However, healing of the bowel anastomosis itself also initiates an 
inflammatory response, which may interfere with the diagnostic accuracy of 
FDG-PET to detect anastomotic leakage at an early stage. The results of our 
study indicate that the normal healing process at the anastomotic site does 
not increase the uptake of FDG, resulting in a high specificity of FDG-PET. 
In only one patient pathologically increased FDG uptake at the site of the 
anastomosis was observed. Pathology revealed Crohn’s disease, but without 
disease activity at the resection margins.  Although FDG-PET correlates well with 
disease activity in patients with inflammatory bowel disease, it is questionable if 
this is an explanation for the increased uptake in our patient since the resection 
margins were free of disease activity. Thus, this patient has to be considered as
a false positive.(13;14)  The advantage of FDG-PET is that it 
can recognize other foci of infection that can clarify patients’ 
complaints. We found other FDG-avid lesions in two patients who had 
a normal FDG accumulation at the site of the anastomosis.    
One patient had a cholecystitis (Figure 3); the other patient underwent 
an adhesiolysis for dense adhesions of the colon to the abdominal wall 
after Hartmann’s procedure for perforated diverticulitis.  
Since uptake of FDG in a colorectal anastomosis is normal and specificity 
is high, FDG-PET might indeed be a valuable diagnostic tool to detect 
anastomotic dehiscence in future. Further research is needed to determine 
its diagnostic value, and particular sensitivity and positive predictive value. 
Furthermore, it is important to define precise criteria in which cases FDG-PET 
is indicated. Routine scanning after all colorectal resections is not useful. If the 
sensitivity of FDG-PET scan proves to be high it could be a valuable diagnostic 
tool in high-risk cases and patients suspected for anastomotic leakage.
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Figure 3. Incidental finding of cholecystitis.
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General discussion
Enhanced Recovery After Surgery is beneficial for patients undergoing colorectal 
surgery. It is associated with a reduction in postoperative morbidity and 
shortens hospital stay after both colonic and rectal surgery. For this reason, 
ERAS should become standard of care after colorectal resection.  
Although the multimodal ERAS program proved to be beneficial for our patients, 
the protocol was breached in a considerable number of patients and 30% of the 
preset goals, regarding epidural anaesthesia, early mobilization, oral intake 
and fluid management, were not met. This was partly due to the development 
of postoperative complications, but other factors may have contributed as well. 
Improved protocol adherence may contribute to better results. Therefore its 
impact on the outcome of patients should gain more attention in future studies. 
The ERAS program is beneficial even with only moderate protocol adherence, 
but one should question which elements contributes most to this effect. 
Epidural anaesthesia is thought to be of major importance in Enhanced 
Recovery after Surgery.(1,2) Although there is evidence that epidural analgesia 
has advantages, the effects may be more moderate as is thought. (3,4)
In Chapter 3, it was concluded that postoperative care following ERAS was 
associated with a reduction in adverse outcome and hospital stay. There 
was no difference in epidural use between the ERAS group and those who 
had conventional postoperative care, so the beneficial effects is more likely 
to be explained by other elements of ERAS. It was concluded in Chapter 4 
that ERAS was useful after rectal surgery. The use of epidural anaesthesia 
was also comparable in the populations studied after rectal surgery. 
This seriously questions the role of epidural anaesthesia as a reason for the found 
differences in postoperative recovery. Epidural failure was studied in more detail 
in Chapter 5. The incidence of solitary epidural failure was about 25% in colonic 
surgery. This represents a considerable proportion of patients, but epidural 
failure did not interfere with surgical outcome. There was no difference in 
morbidity and hospital stay between patients with adequate epidural anaesthesia 
according to the protocol and those in who epidural anaesthesia failed. 
The incidence of epidural failure was lower in rectal surgery (12.2%). 
This may be explained by different pain blockade of epidural anaesthesia after 
surgical procedures performed in the pelvis. Inadequate blockade
may go unnoticed due to the simultaneous use of intravenous opioids
for pain not relieved by epidural anaesthesia.  
Although the use of epidural anaesthesia is advocated in fast-track 
colorectal surgery, some reports, including the results of this thesis, suggest 
that early mobilisation and timely resuming a normal diet have a more 
prominent effect on postoperative recovery than epidural analgesia.(5-7) 
A randomized controlled trial should be undertaken in order to assess the 
role of epidural anaesthesia in a enhanced recovery program more clearly. 
General discussion
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The development and implementation of the fast-track surgery has profound 
implications for the future. One question is how enhanced recovery might evolve.(8) 
Further research is necessary to unravel which factors are most beneficial and 
should receive most attention in the recovery after colorectal surgery, in order 
to optimize ERAS. All efforts should be made to reduce perioperative risks 
and morbidity, instead of focusing on hospital stay as the primary outcome. 
Anaesthetic and (minimally invasive) surgical techniques should be assessed and 
developed further to reduce the surgical stress response. This thesis suggests 
that perioperative fluid management plays an important role on postoperative 
recovery. Although daily fluid balances received a lot of attention in the 
ERAS program under study, fluid overloading was very frequent with a negative 
impact on surgical outcome. Optimization of fluid supply in fast track surgery 
should be subject of further study. As put out in the meta-analysis in Chapter 6, 
current fluid regimes are not compared in a fast-track program. Whether esophageal 
Doppler fluid monitoring is helpful or not in fast track surgery needs further study. 
 
It is obvious that Enhanced Recovery After Surgery has a positive impact on 
surgical outcome and clinicians will have to face the challenges of optimizing 
and integrating fast-track surgery in the care of patients undergoing colorectal
procedures. 
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Summary
The multimodal approach as developed by Hendrik Kehlet, aims to reduce 
the surgical stress response with subsequent increased demands on organ 
function. All elements in the program have shown to improve patient 
outcome separately. The effects on surgical outcome of those elements 
implemented in an enhanced recovery program are studied widely since. 
In the year 2006, the enhanced recovery program was introduced in the Department 
of Surgery of the Radboud University Nijmegen Medical Centre, Nijmegen, 
the Netherlands. The effects of this program are evaluated in this thesis. 
In order to assess the influence of an enhanced recovery program, it is necessary 
to adequately compare patient populations. In Chapter 2, the accuracy of 
preoperative risk prediction with Physiological and Operative Severity Score for 
the eNumeration of Mortality and morbidity (POSSUM), Portsmouth-POSSUM, 
colorectal POSSUM and the Association of Coloproctology of Great Britain and 
Ireland (ACPGBI) score was assessed. When POSSUM is applied for patients 
undergoing colorectal resections for malignancy, inflammatory bowel diseases 
or diverticulitis, the most accurate mortality predictions with any of the POSSUM 
scores was in patients with diverticulitis. POSSUM scores overestimated mortality 
in the carcinoma group. ACPGBI scoring was found to be superior in predicting 
mortality after resection of colorectal cancer in both elective and acute 
interventions. Lowest mortality POSSUM scores were found in patients with 
inflammatory bowel disease, which corresponded with the observed death rate. 
POSSUM underestimated morbidity in this population. This study 
questions the role of POSSUM and ACPGBI in patient comparison 
and the prediction of surgical outcome. For this reason, 
the risk prediction models had no prominent role in the following studies of this 
thesis.           
          
In Chapter 3, a historic cohort study with carefully matched controls to 
assess the effects of an Enhanced Recovery After Surgery (ERAS) program 
after colorectal surgery is described. The results of this study indicate that 
care delivered by ERAS is superior to conventional postoperative care for 
patients undergoing elective colorectal resection. Patients treated according 
to an ERAS program develop significantly less complications and spent 
significantly less time in the hospital. This did not result in more readmissions. 
This study demonstrates that the program as a whole is clearly beneficial and not 
flawed with unexpected negative effects.      
It is known that surgical outcome differs after colonic and rectal surgery. The impact 
of ERAS in patients undergoing rectal surgery is studied in Chapter 4. A cohort 
study with carefully case-matched controls undergoing rectal surgery, resulting 
in two highly comparable groups, was undertaken. ERAS perioperative care was 
found to reduce length of hospital stay after low anterior resection and 
abdominoperineal resection. The use of epidural anaesthesia, readmission rates, 
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mortality and morbidity did not change significantly. In this study, patients within 
ERAS mobilized faster, resumed normal diets sooner with quicker return of 
gastrointestinal function and the duration of intravenous fluid administration 
was shorter.        
In conclusion, this study shows that ERAS helps to reduce hospital stay after
low anterior and abdominoperineal resections.  
One of the most important questioned raised in studying the effects of ERAS in 
colonic and rectal surgery, is which key element(s) is (are) responsible for the 
improvements in surgical outcome. This led to the descriptive study as described 
in Chapter 5. For this study, definitions had to be formulated of how and when 
ERAS was considered to have failed. It appeared that about 30% of the goals  
regarding epidural use, mobility and dietary intake are not reached in an ERAS
program. Over half of the patients undergoing colonic and rectal resections
do not meet one or more goals of the protocol. The number of patients 
experiencing complications does not differ between the population
able to fulfill ERAS goals and those who  are not.   
Total complication rate was higher in ERAS failures. The more severe 
complications were found to decrease protocol compliance. Patients who
manage to reach protocol goals are hospitalized shorter after (open and 
laparoscopic) colonic and rectal surgery. The findings of this study suggest that 
the influence of epidural analgesia is remote in colonic surgery, and its role in 
rectal surgery is even less clear. Impairment in early mobility is associated 
with prolonged hospital stay. The ability to fulfil ERAS dietary guidelines is 
diminished due to complications after colonic surgery. Problematic dietary 
intake has a less prominent relationship with complications and hospital stay 
after rectal surgery. Intravenous fluid overloading is associated with ERAS 
failure and the occurrence of complications and should receive attention.
In order to optimize intravenous fluid supply, the value of intraoperative 
esophageal Doppler was assessed in a meta-analysis in Chapter 6. After reviewing 
the literature, it had to be concluded that the use of esophageal Doppler seems 
to have moderate advantages to optimize fluid management during surgery. 
It increases stroke volume and prolongs corrected flow time. 
Moreover, it reduces total complication rate and the time to tolerate oral 
food intake. However, these findings have to be interpreted with caution.
Heterogeneity between randomized trials published so far, is considerable.
Since all trials under study are found to have reasonable methodology, 
inferior study quality is not likely to be responsible for this heterogeneity.
A major limitation of selected trials is the use of poorly defined outcome 
measures. This limits pooling of data and threatens conclusions on 
the value of esophageal Doppler monitoring. It is likely that trials to 
determine the effect of Doppler guided fluid titration are troubled by 
the changes in perioperative care and surgical technique.  
One of the main consequences of the implementation of an enhanced recovery 
program is a shortened hospital stay. This may interfere with latent symptoms 
of complications. Early discharge without an increase in readmission rate is 
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possible only if patients deviating from the normal postoperative course are 
recognized early after surgery. Anastomotic leakage remains one of the most 
serious adverse events after colorectal surgery. It was hypothesized that F-18-
fluorodeoxyglucose positron emission tomography/ computer tomography 
(FDG-PET/CT) might be helpful to diagnose anastomotic dehiscence at an early 
stage since uptake of FDG will probably be increased due to inflammation by 
leakage of bowel contents. However, healing of the bowel anastomosis itself 
also initiates an inflammatory response, which may interfere with the diagnostic 
accuracy of FDG-PET/CT to detect anastomotic leakage at an early stage. 
Since negligible uptake of F-18-fluorodeoxyglucose (FDG) at the site of the healing 
anastomosis is a prerequisite for early and accurate diagnosis of anastomotic 
dehiscence, we performed a prospective observational pilot study to assess 
postoperative FDG uptake in colonic and colorectal anastomosis in patients 
without evidence of active infection or anastomotic leakage, as described in 
Chapter 7. Patients that underwent colorectal surgery with primary anastomosis 
received FDG-PET/CT of the abdomen, 2-6 days postoperatively. The results show 
that FDG uptake in colorectal anastomosis remains low within the first 6 days 
after surgery in patients without anastomotic leakage. Since uptake of FDG in a 
colorectal anastomosis is normal and specificity is high, FDG-PET/CT might indeed 
be a valuable diagnostic tool to detect anastomotic dehiscence in the future.
Summary
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De multimodale benadering zoals geïnitieerd door Hendrik Kehlet in 1997, heeft 
als doel de chirurgische stress respons met de begeleidende verhoogde arbeid 
door orgaansystemen te doen reduceren. De voordelige effecten van de separate 
elementen in deze aanpak zijn vastgesteld. Of de combinatie van deze elementen, 
samengevoegd in een enhanced recovery after surgery program, voordelen heeft 
in de perioperatieve zorg en chirurgische uitkomst wordt uitvoerig onderzocht. 
In 2006 is enhanced recovery after surgery geïntroduceerd op de afdeling chirurgie 
van het Universitair Medisch Centrum St. Radboud, Nijmegen, Nederland. 
De effecten van deze implementatie worden geëvalueerd in dit proefschrift. 
Hoofdstuk 1 begint met een korte introductie en uitleg over de inhoud en 
opzet van dit proefschrift. Om de effecten van het ERAS programma goed 
te kunnen vast stellen is het essentieel om de patiëntenpopulaties adequaat 
te kunnen vergelijken. In Hoofdstuk 2 is de accuratesse getoetst van de 
Physiological and Operative Severity Score for the eNumeration of Mortality 
and morbidity (POSSUM), Portsmouth-POSSUM, colorectal POSSUM en de 
Association of Coloproctology of Great Britain and Ireland (ACPGBI) score.
Indien POSSUM toegepast wordt bij patiënten die geopereerd worden omwille 
van een maligniteit, inflammatoire darmziekte of diverticulitis, geeft POSSUM 
de meest accurate voorspelling van mortaliteit bij patiënten met diverticulitis. 
POSSUM overschat de sterfte bij patiënten die geopereerd worden aan een 
maligne aandoening. De ACPGBI score is in deze populatie superieur aan 
POSSUM, zowel na electieve als acute operatie. Patiënten met een inflammatoire 
darmziekte hebben de laagste POSSUM scores, die goed overeenkomen met de 
werkelijke mortaliteit. POSSUM onderschat de morbiditeit in deze populatie. 
De resultaten van deze studie trekken het gebruik van POSSUM om 
te komen tot een adequate vergelijking van chirurgische uitkomsten 
tussen ziekenhuizen en accurate individuele risico predictie in twijfel.
In Hoofdstuk 3 zijn de effecten van Enhanced Recovery After Surgery (ERAS) 
onderzocht middels een historische cohort studie met vergelijkbare controle 
patiënten. ERAS was superieur aan conventionele perioperatieve conventionele 
zorg voor patiënten die een electieve colorectale resectie ondergingen. Patiënten 
die behandeld werden volgens ERAS hadden minder complicaties en waren minder 
lang opgenomen. De gevonden kortere opnameduur resulteerde niet in meer
heropnames. De resultaten van dit onderzoek pleiten voor een duidelijk 
voordelig effect van de implementatie van ERAS. Het is dan ook omwille van 
deze reden dat Enhanced Recovery After Surgery tot standaard verheven moet 
worden in de zorg voor patiënten die een colorectale resectie ondergaan. 
Het is bekend dat de uitkomsten van patiënten die een colon resectie ondergaan 
verschillen van patiënten die een resectie van het rectum nodig hebben. De 
waarde van ERAS bij rectum resectie wordt gespecificeerd in Hoofdstuk 4. Hier 
wordt een cohort vergeleken met een vergelijkbare historische controle groep. 
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Het resultaat van dit onderzoek is dat ERAS de opnameduur na een low anterior 
of abdominoperineale resectie verkort. Het gebruik van epidurale anesthesie, 
mortaliteit en morbiditeit was vergelijkbaar. Patiënten die behandeld worden 
met ERAS mobiliseren sneller, hervatten het eten eerder met sneller herstel van 
de gastro-intestinale functie en zijn minder lang afhankelijk van intraveneuze 
vochttoediening. Gezien de gevonden voordelige effecten van ERAS bij rectum 
resecties lijkt het verstandig deze zorg als standaard te implementeren.
Een van de meest essentiële vragen die het ERAS programma oproept is welke 
van de elementen de grootste invloed heeft op de verbeterde uitkomsten. Dit 
is onderzocht in een beschrijvende studie zoals beschreven in Hoofdstuk 5. 
Dit onderzoek vereiste het formuleren en definiëren van het falen van ERAS. 
Het blijkt dat ongeveer 30% van de doelen die gesteld zijn aan het epiduraal 
gebruik, spoedig mobiliseren en hervatten van normale voeding niet gehaald 
worden in een ERAS programma. Meer dan de helft van de patiënten die een 
resectie van het colon of rectum ondergaan kan niet voldoen aan een of meer 
van de gestelde doelen. Hoewel er in absolute zin meer complicaties gevonden 
worden in de populatie die het programma faalt, is er geen verschil in het aantal 
patiënten die een complicatie ontwikkelen tussen de groep die er in slaagt de 
gestelde doelen te halen en de groep die hiertoe niet in staat is. Het optreden 
van ernstige complicaties doet de protocol compliantie verlagen. Patiënten 
die in staat zijn aan de gestelde doelen te voldoen zijn korter opgenomen 
na zowel (open en laparoscopische) colectomie en na een rectum resectie.
De bevindingen van deze studie suggereren dat de invloed van epidurale anesthesie 
op het bespoedigen van het postoperatief herstel beperkt is. Belemmering in 
het spoedig mobiliseren na een operatie zorgt voor een verlengde opname duur. 
Na een resectie van het colon is er een relatie tussen het optreden van complicaties 
en het niet kunnen naleven van de doelstellingen omtrent het hervatten van een 
normaal dieet. Na rectum chirugie is deze associatie minder evident. 
Het overmatig toedienen van intraveneus vocht is gerelateerd aan ERAS 
falen en het optreden van complicaties.    
Ten einde meer inzicht te verkrijgen in de optimalisatie van intraveneuze 
vochttoediening, werd de waarde van intra-operatieve oesofagiale Doppler 
tijdens colorectale ingrepen onderzocht in een meta-analyse, zoals beschreven 
in Hoofdstuk 6. Na het reviewen van de literatuur, moet geconcludeerd worden 
dat het gebruik van intra-operatieve oesofagiale Doppler beperkte voordelen 
lijkt te hebben: het slagvolume is hoger, net als de ‘ corrected flow time’. Er 
zijn minder complicaties en de tijd tot het tolereren van voeding is verkort 
in patiënten die tijdens de operatie vocht toegediend krijgen met behulp van 
oesofagiale Doppler. Echter, deze conclusies moeten genuanceerd worden. De 
heterogeniteit tussen de onderzochte gerandomiseerde studies is aanzienlijk 
en waarschijnlijk niet te wijten aan een verminderde methodologische 
kwaliteit. Een andere belangrijke beperking is het gebruik van slecht 
gedefinieerde uitkomstmaten, wat het analyseren van data bemoeilijkt en 
de conclusies van dit onderzoek ondermijnen. Het is niet onwaarschijnlijk dat 
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verbeteringen in perioperatieve zorg en chirurgische techniek een rol spelen.
Een van de effecten van ERAS is een kortere opnameduur. Het is niet ondenkbaar 
dat dit interfereert met latente symptomen van complicaties. De meest ernstige 
complicatie na colorectale resecties vanwege de duidelijke associatie met 
mortaliteit is naadlekkage. Het vroegtijdig onderkennen van naadlekkage is 
essentieel voor snelle behandeling en het voorkomen van verdere verslechtering 
van de toestand van de patiënt. Een verdere risico reductie in colorectale 
chirurgie kan bereikt worden door een vroege detectie van naadlekkage. Het 
stellen van de diagnose op klinische gronden is moeizaam en ook bestaande 
radiologische technieken hebben ernstige beperkingen. Een hypothese is dat 
F-18-fluorodeoxyglucose positron emission tomography (FDG-PET) een rol kan 
spelen in de vroege detectie van naaddehiscentie omdat de opname van F-18-
fluorodeoxyglucose (FDG) waarschijnlijk verhoogd is door inflammatie door de 
lekkage van darminhoud. Echter, het genezingsproces van de darm anastomose 
kent ook een inflammatoire respons. Dit kan interfereren met de diagnostisch 
accuratesse van de FDG-PET om naadlekkage in een vroege fase te ontdekken. 
De belangrijkste voorwaarde om te komen tot een accurate detectie van 
naadlekkage is een verwaarloosbare opname van F-18-fluorodeoxyglucose  ter 
plaatse van een normaal genezende darmanastomose. Hoofdstuk 7 beschrijft 
de resultaten van een prospectieve observationele studie om de opname van 
F-18-fluorodeoxyglucose in colon, dan wel colorectale, anastomose  in kaart 
te brengen bij patiënten zonder aanwijzingen voor een actieve infectie dan 
wel naadlekkage. Patiënten ondergingen 2 tot 6 dagen na colorectale chirurgie 
met aanleg van een primaire anastomose, eenmalig F-18-fluorodeoxyglucose 
positron emission tomography. De opname van F-18-fluorodeoxyglucose bleek 
laag gedurende de eerste 6 dagen na operatie bij patiënten zonder klinisch 
relevante naadlekkage. Omdat de opname van FDG in een normaal genezende 
colorectale anastomose laag en de specificiteit hoog is, is het mogelijk dat FDG-
PET behulpzaam kan zijn om naadlekkage in een vroeg stadium aan te tonen. 
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Een proefschrift maak je niet alleen. Ik ben veel mensen dan ook dank 
verschuldigd. Enkele personen zou ik in het bijzonder willen bedanken.
Prof. Dr. R.P. Bleichrodt
Beste Rob, zonder jou was ik waarschijnlijk geen AGNIO, AIOS chirurgie of 
spreker op diverse congressen geweest en was dit boekje er niet gekomen. 
Vele malen stapte ik vol trots ik met mijn concepten je kamer binnen, vaak 
kwam ik gedesillusioneerd weer naar buiten. Echter, je inzicht was altijd 
bewonderenswaardig en kwam de inhoud alleen maar ten goede. 
Ik ben je erg dankbaar en wens je niets dan goed. 
Dr. A.J.A. Bremers
Beste Andre, je stak veel tijd en moeite in de begeleiding van “Jut en Jul” en het 
verhaal van de acute colectomien. Hierna bleef je erg bereikbaar en actief bij de 
verdere totstandkoming van dit proefschrift. Bedankt hiervoor!
Manuscriptcommissie
Mijn hartelijke dank voor het beoordelen van mijn manuscript.
MSc. J.M.M. Groenewoud
Beste Hans, zonder jou hulp met de statistiek was dit schrijven er (nog) niet 
geweest. Jij wist mijn uitvoerige tabellen altijd om te toveren tot bruikbare 
berekeningen. Bedankt voor je niet aflatende hulp en geduld met mij. 
Dr. T. Hendriks
Beste Thijs, ook al waren we het niet altijd roerend eens en moest ik je nogal 
eens overtuigen van mijn plannen: Ik kan nu pas toegeven dat je ook wel eens 
gelijk had...
Professor Dr. W.J.G. Oyen
Beste Wim, buitengewoon verbaasd was ik over ieders bereidwilligheid en 
het onderzoek klimaat op de afdeling Nucleaire Geneeskunde. Dank voor het 
faciliteren van het klinische en experimentele naadlekkage onderzoek!
Dr. L.F. de Geus-Oei
Beste Lioe- Fee, het was een eer met je te werken. Bedankt voor het beoordelen 
van de PET scans en je bijdrage aan dit schrijven. Je revisies waren snel en het 
commentaar altijd motiverend.
Drs. M.W.J. Stommel
Beste Martijn, de wortels van dit proefschrift hebben we samen geplant. 
Hoogtepunten waren de “pooled patients data” en het mee schreeuwen met 
Amerie in de tuin van Omnivagus. 
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Drs. S. de Zeeuw en Drs. R.J. van der Vijver
Jullie betrekken bij het PET NAAD onderzoek bleek een goede zet. Roos, petje af 
voor je hulp bij het dierexperiment! Succes met jullie opleiding en het afronden 
van jullie promoties!
Drs. C. Strik
Beste Chema, jij was de eerste student die ik mocht begeleiden met een 
wetenschappelijke stage. Ik wens je veel succes met het ontwikkelen van je 
carrière.
Secretariaat chirurgie UMCN St Radboud
Hartelijk dank voor jullie ondersteuning in het opvragen van de vele dossiers en 
het plannen van afspraken. Jannie en Esther, dank voor jullie inspanningen in de 
afrondende fase!
Medewerkers polikliniek en opnamebureau chirurgie UMCN St Radboud
Jullie waren de spil in het includeren van patiënten. In het bijzonder wil ik 
Jacques Peters bedanken voor zijn voortdurende inspanningen de studie onder de 
aandacht te houden.
Medewerkers van het archief
Volle karren met statussen werden uit jullie ruimte geplunderd. Bedankt voor 
jullie hulp, vooral met het weer opruimen ervan… Mario: Handdoek!
Chirurgen en collega-assistenten UMC St Radboud Nijmegen
Dank voor jullie collegialiteit en belangstelling. Jullie maken de drukke dagen de 
moeite waard. Het Radboud voelt altijd als een beetje thuis komen.  
Chirurgen en collega-assistenten Rijnstate Ziekenhuis Arnhem
Het is een voorrecht om het perifere deel van mijn opleiding bij jullie te mogen 
genieten. 
Vrienden en vriendinnen
Bedankt dat jullie niks bijgedragen hebben aan dit proefschrift behoudens de 
meer dan welkome momenten die zorgden voor afleiding.
Leden van de Hot Five
Beste Dominique, Maarten, Jillis en Harm. We zijn een mooi clubje geworden! 
Dat we nog maar vaak een weekendje weg mogen samen… ;-)
Leden van de Men Only
Beste Wielie (de Woeste), Humphrey en Maurice. Al heel wat jaren genieten we 
telkens weer van onze maandelijkse culinaire avond. Ik heb nu al weer zin in de 
volgende!
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Dr. M. Truijers
Beste Maarten, jou hoef ik eigenlijk niet zoveel te zeggen. Het zit wel goed, 
maat. Fijn dat je mijn paranimf wil zijn.
Renate, Maikel en Noor
Jullie hebben vaak gevraagd hoe het er mee was, maar nu kan ik echt zeggen dat 
het af is. Ik heb jullie lief. Een wiebeltje voor Noor!
Ella en Wielie
Wat mag ik jullie graag! Altijd oprecht geïnteresseerd. Voor de een: ‘Once upon a 
time in the West!’ en  ‘un dieke’ voor de ander…
Maurice Teeuwen
Beste broer! Onvoorwaardelijk kan ik op jou rekenen. Zoals ons leven tot dusver, 
sta je ook vandaag weer pal naast me. Fijne vent!
Nadine Teeuwen
Beste zus! Dit is ook het kroontje op jouw werk! Ik sta altijd voor je klaar.
Pieter en Astrid Teeuwen
Beste pap en mam, jullie maakten mij tot wie ik ben en stelden mij in de 
gelegenheid mijn doelen na te streven. Mijn liefde en dank is groot: ik houd van 
jullie!
Linda
Elke dag met jou is een feest. Wat is het toch makkelijk om heel veel van je te 
houden. 
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Curriculum Vitae
Pascal Teeuwen werd geboren op 16 september 1980 te Reuver. Hij behaalde zijn 
atheneum diploma aan het Bisschoppelijk College Broekhin te Roermond in 1998. 
Hierna studeerde hij gezondheidswetenschappen aan de Universiteit van Maastricht, 
waar hij in 1999 de propedeuse bemachtigde. In 1999 startte hij met de studie 
geneeskunde aan de Radboud Universiteit Nijmegen. Gedurende de klinische fase 
van deze studie werd de interesse voor de chirurgie gewekt. Tijdens zijn coschap 
chirurgie werd het onderzoek gestart, later uitmondend in een wetenschappelijke 
stage. Na het behalen van zijn artsexamen in 2005 werkte hij bijna 2 jaar als 
arts-assistent heelkunde niet in opleiding in het UMC St Radboud te Nijmegen.
In 2007 begon de opleiding tot chirurg in het UMC St Radboud te Nijmegen 
(opleider: Professor Dr. R.P. Bleichrodt). In 2009 volgden twee opleidingsjaren 
in het Rijnstate ziekenhuis te Arnhem (opleider: Dr. M.M.P.J. Reijnen). 
Het eerste deel van zijn tweejarige differentiatie binnen de gastroenterologische 
en oncologische chirurgie vond wederom plaats in het UMC St Radboud 
(opleider: Professor Dr. C.J.H.M. van Laarhoven). In juli 2012 is gestart 
met het laatste jaar in het Rijnstate ziekenhuis te Arnhem (opleider: Dr. 
M.M.P.J. Reijnen), waar de opleiding tot chirurg zal worden voltooid in 2013. 
Curriculum Vitae
Stellingen behorende bij het proefschrift
Perioperative care in colorectal surgery
Zolang uniforme definities van chirurgische uitkomsten ontbreken, heeft het geen 
zin risico predictie modellen te ontwikkelen. dit proefschrift
Het aanwenden van een Enhanced Recovery After Surgery programma bij de 
behandeling van patiënten die een electieve colorectale resectie ondergaan gaat 
gepaard met een reductie in morbiditeit en opnameduur. dit proefschrift
Meer dan de helft van de patiënten die een colorectale resectie ondergaan kan niet 
voldoen aan een of meer van de doelstellingen zoals gesteld binnen het Enhanced 
Recovery After Surgery programma, waarbij het optreden van ernstige complicaties 
in belangrijke mate interfereert met protocol compliantie. dit proefschrift
De waarde intra-operatief Doppler-geleide vochttoediening is niet eenduidig door 
de heterogeniteit van de verrichtte studies en de eventueel verstorende invloeden 
van verbeterde perioperatieve zorg en chirurgische technieken. dit proefschrift
De opname van F-18-fluorodeoxyglucose in een colorectale anastomose is laag bij 
patiënten die geen (klinisch relevante) naadlekkage ontwikkelen. dit proefschrift
As long as the abdomen is open you control it. Once closed, it controls you. 
Moshe Schein
Beknoptheid is de ziel van de wijsheid. Shakespeare
One should advise surgery only if there is a reasonable chance of success. To 
operate without having a chance means to prostitute the beautiful art and science 
of surgery. Theodor Billroth 1829-1894
If one does not fail at times, than one has not challenged himself. 
Ferdinand Porsche, 1875-1951
Volgens de uitspraak ‘De aanval is de beste verdediging’ zou de promovendus 
vragen aan de corona moeten stellen.
De promovendus is een van de weinigen die opgelucht is als zijn laatste uur 
geslagen heeft.
        
Pascal H.E. Teeuwen
                 Nijmegen, 2012
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Uitnodiging
Voor het bijwonen van
de openbare verdediging
van mijn proefschrift
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Op donderdag 
13 december 2012
om 10.30 uur
De promotie zal 
plaatsvinden
in de aula van de
Radboud Universiteit 
Nijmegen,
Comeniuslaan 2 te Nijmegen
Na afloop van de promotie 
bent u van harte 
uitgenodigd voor de receptie 
ter plaatse.
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